bio-datasets/bigbio-ner-merged · Datasets at Hugging Face

answer stringlengths 1 16.1k	id stringlengths 7 56	instruction stringlengths 106 72.6k	ner_tags list	text stringlengths 5 72.4k	tokens list	types list
Pionierzeit is an umlsterm, Replantation is an umlsterm, Extremitaet is an umlsterm, Schmerzen is an umlsterm, Replantation is an umlsterm, Unfallmechanismus is an umlsterm, Replantation is an umlsterm, Patienten is an umlsterm	DerUnfallchirurg.71000694.ger.abstr_task0	Sentence: In der Pionierzeit der Replantationschirurgie wurde der Erfolg alleine an der Vitalitaet des Replantates ( Ueberlebensrate ) gemessen . Spricht man heute von einer erfolgreichen Replantation muessen neben der Vitalitaet zusaetzliche Kriterien wie , ein geringes Replantationsrisiko , eine funktionelle Extremit...	[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O...	In der Pionierzeit der Replantationschirurgie wurde der Erfolg alleine an der Vitalitaet des Replantates ( Ueberlebensrate ) gemessen . Spricht man heute von einer erfolgreichen Replantation muessen neben der Vitalitaet zusaetzliche Kriterien wie , ein geringes Replantationsrisiko , eine funktionelle Extremitaet " " na...	[ "In", "der", "Pionierzeit", "der", "Replantationschirurgie", "wurde", "der", "Erfolg", "alleine", "an", "der", "Vitalitaet", "des", "Replantates", "(", "Ueberlebensrate", ")", "gemessen", ".", "Spricht", "man", "heute", "von", "einer", "erfolgreichen", "Replantation...	[ "umlsterm" ]
Pionierzeit is an umlsterm, Replantation is an umlsterm, Extremitaet is an umlsterm, Schmerzen is an umlsterm, Replantation is an umlsterm, Unfallmechanismus is an umlsterm, Replantation is an umlsterm, Patienten is an umlsterm	DerUnfallchirurg.71000694.ger.abstr_task1	Sentence: In der Pionierzeit der Replantationschirurgie wurde der Erfolg alleine an der Vitalitaet des Replantates ( Ueberlebensrate ) gemessen . Spricht man heute von einer erfolgreichen Replantation muessen neben der Vitalitaet zusaetzliche Kriterien wie , ein geringes Replantationsrisiko , eine funktionelle Extremit...	[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O...	In der Pionierzeit der Replantationschirurgie wurde der Erfolg alleine an der Vitalitaet des Replantates ( Ueberlebensrate ) gemessen . Spricht man heute von einer erfolgreichen Replantation muessen neben der Vitalitaet zusaetzliche Kriterien wie , ein geringes Replantationsrisiko , eine funktionelle Extremitaet " " na...	[ "In", "der", "Pionierzeit", "der", "Replantationschirurgie", "wurde", "der", "Erfolg", "alleine", "an", "der", "Vitalitaet", "des", "Replantates", "(", "Ueberlebensrate", ")", "gemessen", ".", "Spricht", "man", "heute", "von", "einer", "erfolgreichen", "Replantation...	[ "umlsterm" ]
Pionierzeit, Replantation, Extremitaet, Schmerzen, Replantation, Unfallmechanismus, Replantation, Patienten	DerUnfallchirurg.71000694.ger.abstr_task2	Sentence: In der Pionierzeit der Replantationschirurgie wurde der Erfolg alleine an der Vitalitaet des Replantates ( Ueberlebensrate ) gemessen . Spricht man heute von einer erfolgreichen Replantation muessen neben der Vitalitaet zusaetzliche Kriterien wie , ein geringes Replantationsrisiko , eine funktionelle Extremit...	[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O...	In der Pionierzeit der Replantationschirurgie wurde der Erfolg alleine an der Vitalitaet des Replantates ( Ueberlebensrate ) gemessen . Spricht man heute von einer erfolgreichen Replantation muessen neben der Vitalitaet zusaetzliche Kriterien wie , ein geringes Replantationsrisiko , eine funktionelle Extremitaet " " na...	[ "In", "der", "Pionierzeit", "der", "Replantationschirurgie", "wurde", "der", "Erfolg", "alleine", "an", "der", "Vitalitaet", "des", "Replantates", "(", "Ueberlebensrate", ")", "gemessen", ".", "Spricht", "man", "heute", "von", "einer", "erfolgreichen", "Replantation...	[ "umlsterm" ]
transfer is an umlsterm, safety is an umlsterm, interaction is an umlsterm, teleradiology is an umlsterm, selection is an umlsterm	DerRadiologe.70370336.eng.abstr_task0	Sentence: Teleradiologysystems can differ considerably in their features . The most important differences lie in the mode of image data acquisition , data transfer , data safety aspects and the possibilities of interaction between seperate teleradiology units . A selection of commercially available teleradiologysystems...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", ...	Teleradiologysystems can differ considerably in their features . The most important differences lie in the mode of image data acquisition , data transfer , data safety aspects and the possibilities of interaction between seperate teleradiology units . A selection of commercially available teleradiologysystems is presen...	[ "Teleradiologysystems", "can", "differ", "considerably", "in", "their", "features", ".", "The", "most", "important", "differences", "lie", "in", "the", "mode", "of", "image", "data", "acquisition", ",", "data", "transfer", ",", "data", "safety", "aspects", "and"...	[ "umlsterm" ]
transfer is an umlsterm, safety is an umlsterm, interaction is an umlsterm, teleradiology is an umlsterm, selection is an umlsterm	DerRadiologe.70370336.eng.abstr_task1	Sentence: Teleradiologysystems can differ considerably in their features . The most important differences lie in the mode of image data acquisition , data transfer , data safety aspects and the possibilities of interaction between seperate teleradiology units . A selection of commercially available teleradiologysystems...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", ...	Teleradiologysystems can differ considerably in their features . The most important differences lie in the mode of image data acquisition , data transfer , data safety aspects and the possibilities of interaction between seperate teleradiology units . A selection of commercially available teleradiologysystems is presen...	[ "Teleradiologysystems", "can", "differ", "considerably", "in", "their", "features", ".", "The", "most", "important", "differences", "lie", "in", "the", "mode", "of", "image", "data", "acquisition", ",", "data", "transfer", ",", "data", "safety", "aspects", "and"...	[ "umlsterm" ]
transfer, safety, interaction, teleradiology, selection	DerRadiologe.70370336.eng.abstr_task2	Sentence: Teleradiologysystems can differ considerably in their features . The most important differences lie in the mode of image data acquisition , data transfer , data safety aspects and the possibilities of interaction between seperate teleradiology units . A selection of commercially available teleradiologysystems...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", ...	Teleradiologysystems can differ considerably in their features . The most important differences lie in the mode of image data acquisition , data transfer , data safety aspects and the possibilities of interaction between seperate teleradiology units . A selection of commercially available teleradiologysystems is presen...	[ "Teleradiologysystems", "can", "differ", "considerably", "in", "their", "features", ".", "The", "most", "important", "differences", "lie", "in", "the", "mode", "of", "image", "data", "acquisition", ",", "data", "transfer", ",", "data", "safety", "aspects", "and"...	[ "umlsterm" ]
Drucksenkung is an umlsterm, Glaukomaugen is an umlsterm	DerOpthalmologe.70940665.ger.abstr_task0	Sentence: Problemstellung : Wie weit ist eine Drucksenkung bei Glaukomaugen durch punktfoermige Ablation des Trabekelwerks mit dem Excimerlaser moeglich ? Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: umlsterm	[ "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	Problemstellung : Wie weit ist eine Drucksenkung bei Glaukomaugen durch punktfoermige Ablation des Trabekelwerks mit dem Excimerlaser moeglich ?	[ "Problemstellung", ":", "Wie", "weit", "ist", "eine", "Drucksenkung", "bei", "Glaukomaugen", "durch", "punktfoermige", "Ablation", "des", "Trabekelwerks", "mit", "dem", "Excimerlaser", "moeglich", "?" ]	[ "umlsterm" ]
Drucksenkung is an umlsterm, Glaukomaugen is an umlsterm	DerOpthalmologe.70940665.ger.abstr_task1	Sentence: Problemstellung : Wie weit ist eine Drucksenkung bei Glaukomaugen durch punktfoermige Ablation des Trabekelwerks mit dem Excimerlaser moeglich ? Instructions: please typing these entity words according to sentence: Drucksenkung, Glaukomaugen Options: umlsterm	[ "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	Problemstellung : Wie weit ist eine Drucksenkung bei Glaukomaugen durch punktfoermige Ablation des Trabekelwerks mit dem Excimerlaser moeglich ?	[ "Problemstellung", ":", "Wie", "weit", "ist", "eine", "Drucksenkung", "bei", "Glaukomaugen", "durch", "punktfoermige", "Ablation", "des", "Trabekelwerks", "mit", "dem", "Excimerlaser", "moeglich", "?" ]	[ "umlsterm" ]
Drucksenkung, Glaukomaugen	DerOpthalmologe.70940665.ger.abstr_task2	Sentence: Problemstellung : Wie weit ist eine Drucksenkung bei Glaukomaugen durch punktfoermige Ablation des Trabekelwerks mit dem Excimerlaser moeglich ? Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	Problemstellung : Wie weit ist eine Drucksenkung bei Glaukomaugen durch punktfoermige Ablation des Trabekelwerks mit dem Excimerlaser moeglich ?	[ "Problemstellung", ":", "Wie", "weit", "ist", "eine", "Drucksenkung", "bei", "Glaukomaugen", "durch", "punktfoermige", "Ablation", "des", "Trabekelwerks", "mit", "dem", "Excimerlaser", "moeglich", "?" ]	[ "umlsterm" ]
man is an umlsterm, giant - cell is an umlsterm, tumor is an umlsterm, right is an umlsterm, temporomandibular joint is an umlsterm, growth is an umlsterm, treatment is an umlsterm, endotracheal anesthesia is an umlsterm, recurrence is an umlsterm, Differential diagnosis is an umlsterm, therapy is an umlsterm	MundKieferGesichtschirurgie.80020279.eng.abstr_task0	Sentence: A 63-year-old man is presented in whom a tenosynovial giant-cell tumor destroyed the right temporomandibular joint and fossa and showed extensive intracranial growth . Because of uncharacteristic complaints , a symptomatic treatment was performed elsewhere . The lesion was finally resected under endotracheal ...	[ "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "B-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O",...	A 63-year-old man is presented in whom a tenosynovial giant-cell tumor destroyed the right temporomandibular joint and fossa and showed extensive intracranial growth . Because of uncharacteristic complaints , a symptomatic treatment was performed elsewhere . The lesion was finally resected under endotracheal anesthesia...	[ "A", "63-year", "-", "old", "man", "is", "presented", "in", "whom", "a", "tenosynovial", "giant", "-", "cell", "tumor", "destroyed", "the", "right", "temporomandibular", "joint", "and", "fossa", "and", "showed", "extensive", "intracranial", "growth", ".", "Bec...	[ "umlsterm" ]
man is an umlsterm, giant - cell is an umlsterm, tumor is an umlsterm, right is an umlsterm, temporomandibular joint is an umlsterm, growth is an umlsterm, treatment is an umlsterm, endotracheal anesthesia is an umlsterm, recurrence is an umlsterm, Differential diagnosis is an umlsterm, therapy is an umlsterm	MundKieferGesichtschirurgie.80020279.eng.abstr_task1	Sentence: A 63-year-old man is presented in whom a tenosynovial giant-cell tumor destroyed the right temporomandibular joint and fossa and showed extensive intracranial growth . Because of uncharacteristic complaints , a symptomatic treatment was performed elsewhere . The lesion was finally resected under endotracheal ...	[ "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "B-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O",...	A 63-year-old man is presented in whom a tenosynovial giant-cell tumor destroyed the right temporomandibular joint and fossa and showed extensive intracranial growth . Because of uncharacteristic complaints , a symptomatic treatment was performed elsewhere . The lesion was finally resected under endotracheal anesthesia...	[ "A", "63-year", "-", "old", "man", "is", "presented", "in", "whom", "a", "tenosynovial", "giant", "-", "cell", "tumor", "destroyed", "the", "right", "temporomandibular", "joint", "and", "fossa", "and", "showed", "extensive", "intracranial", "growth", ".", "Bec...	[ "umlsterm" ]
man, giant - cell, tumor, right, temporomandibular joint, growth, treatment, endotracheal anesthesia, recurrence, Differential diagnosis, therapy	MundKieferGesichtschirurgie.80020279.eng.abstr_task2	Sentence: A 63-year-old man is presented in whom a tenosynovial giant-cell tumor destroyed the right temporomandibular joint and fossa and showed extensive intracranial growth . Because of uncharacteristic complaints , a symptomatic treatment was performed elsewhere . The lesion was finally resected under endotracheal ...	[ "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "B-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O",...	A 63-year-old man is presented in whom a tenosynovial giant-cell tumor destroyed the right temporomandibular joint and fossa and showed extensive intracranial growth . Because of uncharacteristic complaints , a symptomatic treatment was performed elsewhere . The lesion was finally resected under endotracheal anesthesia...	[ "A", "63-year", "-", "old", "man", "is", "presented", "in", "whom", "a", "tenosynovial", "giant", "-", "cell", "tumor", "destroyed", "the", "right", "temporomandibular", "joint", "and", "fossa", "and", "showed", "extensive", "intracranial", "growth", ".", "Bec...	[ "umlsterm" ]
Metoclopramide is a DRUG, MONUROL is a BRAND, metoclopramide is a DRUG, fosfomycin is a DRUG, Cimetidine is a DRUG, Cimetidine is a DRUG, fosfomycin is a DRUG, MONUROL is a BRAND	Fosfomycin_ddi_task0	Sentence: Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Cimetidine: Cimetidine does not affect the ph...	[ "B-DRUG", "O", "O", "O", "O", "B-BRAND", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "B-DRUG", "O", ...	Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Cimetidine: Cimetidine does not affect the pharmacokine...	[ "Metoclopramide", ":", "When", "coadministered", "with", "MONUROL", ",", "metoclopramide", ",", "a", "drug", "which", "increases", "gastrointestinal", "motility", ",", "lowers", "the", "serum", "concentration", "and", "urinary", "excretion", "of", "fosfomycin", ".",...	[ "DRUG", "BRAND" ]
Metoclopramide is a DRUG, MONUROL is a BRAND, metoclopramide is a DRUG, fosfomycin is a DRUG, Cimetidine is a DRUG, Cimetidine is a DRUG, fosfomycin is a DRUG, MONUROL is a BRAND	Fosfomycin_ddi_task1	Sentence: Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Cimetidine: Cimetidine does not affect the ph...	[ "B-DRUG", "O", "O", "O", "O", "B-BRAND", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "B-DRUG", "O", ...	Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Cimetidine: Cimetidine does not affect the pharmacokine...	[ "Metoclopramide", ":", "When", "coadministered", "with", "MONUROL", ",", "metoclopramide", ",", "a", "drug", "which", "increases", "gastrointestinal", "motility", ",", "lowers", "the", "serum", "concentration", "and", "urinary", "excretion", "of", "fosfomycin", ".",...	[ "DRUG", "BRAND" ]
Metoclopramide, MONUROL, metoclopramide, fosfomycin, Cimetidine, Cimetidine, fosfomycin, MONUROL	Fosfomycin_ddi_task2	Sentence: Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Cimetidine: Cimetidine does not affect the ph...	[ "B-DRUG", "O", "O", "O", "O", "B-BRAND", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "B-DRUG", "O", ...	Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Cimetidine: Cimetidine does not affect the pharmacokine...	[ "Metoclopramide", ":", "When", "coadministered", "with", "MONUROL", ",", "metoclopramide", ",", "a", "drug", "which", "increases", "gastrointestinal", "motility", ",", "lowers", "the", "serum", "concentration", "and", "urinary", "excretion", "of", "fosfomycin", ".",...	[ "DRUG", "BRAND" ]
I - DOX is a chemical, TTR is a protein, FAP is a disease	1.0alpha7.train.194_task0	Sentence: The data presented in this study clearly show that I-DOX binds specifically to TTR amyloid fibrils in tissues from patients with FAP. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: disease, chemical, protein ...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-chemical", "I-chemical", "I-chemical", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "B-disease", "O" ]	The data presented in this study clearly show that I-DOX binds specifically to TTR amyloid fibrils in tissues from patients with FAP.	[ "The", "data", "presented", "in", "this", "study", "clearly", "show", "that", "I", "-", "DOX", "binds", "specifically", "to", "TTR", "amyloid", "fibrils", "in", "tissues", "from", "patients", "with", "FAP", "." ]	[ "chemical", "protein", "disease" ]
I - DOX is a chemical, TTR is a protein, FAP is a disease	1.0alpha7.train.194_task1	Sentence: The data presented in this study clearly show that I-DOX binds specifically to TTR amyloid fibrils in tissues from patients with FAP. Instructions: please typing these entity words according to sentence: I - DOX, TTR, FAP Options: disease, chemical, protein	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-chemical", "I-chemical", "I-chemical", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "B-disease", "O" ]	The data presented in this study clearly show that I-DOX binds specifically to TTR amyloid fibrils in tissues from patients with FAP.	[ "The", "data", "presented", "in", "this", "study", "clearly", "show", "that", "I", "-", "DOX", "binds", "specifically", "to", "TTR", "amyloid", "fibrils", "in", "tissues", "from", "patients", "with", "FAP", "." ]	[ "chemical", "protein", "disease" ]
I - DOX, TTR, FAP	1.0alpha7.train.194_task2	Sentence: The data presented in this study clearly show that I-DOX binds specifically to TTR amyloid fibrils in tissues from patients with FAP. Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-chemical", "I-chemical", "I-chemical", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "B-disease", "O" ]	The data presented in this study clearly show that I-DOX binds specifically to TTR amyloid fibrils in tissues from patients with FAP.	[ "The", "data", "presented", "in", "this", "study", "clearly", "show", "that", "I", "-", "DOX", "binds", "specifically", "to", "TTR", "amyloid", "fibrils", "in", "tissues", "from", "patients", "with", "FAP", "." ]	[ "chemical", "protein", "disease" ]
prostaglandin is a CHEMICAL	12713596_task0	Sentence: Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: CHEMICAL	[ "O", "B-CHEMICAL", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair.	[ "Cyclooxygenase-1-coupled", "prostaglandin", "biosynthesis", "constitutes", "an", "essential", "prerequisite", "for", "skin", "repair", "." ]	[ "GENE-N", "CHEMICAL", "GENE-Y" ]
prostaglandin is a CHEMICAL	12713596_task1	Sentence: Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. Instructions: please typing these entity words according to sentence: prostaglandin Options: CHEMICAL	[ "O", "B-CHEMICAL", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair.	[ "Cyclooxygenase-1-coupled", "prostaglandin", "biosynthesis", "constitutes", "an", "essential", "prerequisite", "for", "skin", "repair", "." ]	[ "GENE-N", "CHEMICAL", "GENE-Y" ]
prostaglandin	12713596_task2	Sentence: Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. Instructions: please extract entity words from the input sentence	[ "O", "B-CHEMICAL", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair.	[ "Cyclooxygenase-1-coupled", "prostaglandin", "biosynthesis", "constitutes", "an", "essential", "prerequisite", "for", "skin", "repair", "." ]	[ "GENE-N", "CHEMICAL", "GENE-Y" ]
I kappaB alpha is a Protein, serines 32 and 36 is a Entity, I kappaB alpha is a Protein, p50 is a Protein, relA is a Protein, I kappaB alpha is a Protein, I kappaB alpha is a Protein, Tax is a Protein, I kappaB beta is a Protein, I kappaB epsilon is a Protein, I kappaB alpha is a Protein, I kappaB beta is a Protein, I ...	9032271_task0	Sentence: Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). Associated with its inhibitor, I kappaB, NF-kappaB re...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). Associated with its inhibitor, I kappaB, NF-kappaB resides as a...	[ "Characterization", "of", "a", "mutant", "cell", "line", "that", "does", "not", "activate", "NF", "-", "kappaB", "in", "response", "to", "multiple", "stimuli", ".", "\n", "Numerous", "genes", "required", "during", "the", "immune", "or", "inflammation", "respon...	[ "Entity", "Protein" ]
I kappaB alpha is a Protein, serines 32 and 36 is a Entity, I kappaB alpha is a Protein, p50 is a Protein, relA is a Protein, I kappaB alpha is a Protein, I kappaB alpha is a Protein, Tax is a Protein, I kappaB beta is a Protein, I kappaB epsilon is a Protein, I kappaB alpha is a Protein, I kappaB beta is a Protein, I ...	9032271_task1	Sentence: Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). Associated with its inhibitor, I kappaB, NF-kappaB re...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). Associated with its inhibitor, I kappaB, NF-kappaB resides as a...	[ "Characterization", "of", "a", "mutant", "cell", "line", "that", "does", "not", "activate", "NF", "-", "kappaB", "in", "response", "to", "multiple", "stimuli", ".", "\n", "Numerous", "genes", "required", "during", "the", "immune", "or", "inflammation", "respon...	[ "Entity", "Protein" ]
I kappaB alpha, serines 32 and 36, I kappaB alpha, p50, relA, I kappaB alpha, I kappaB alpha, Tax, I kappaB beta, I kappaB epsilon, I kappaB alpha, I kappaB beta, I kappaB epsilon	9032271_task2	Sentence: Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). Associated with its inhibitor, I kappaB, NF-kappaB re...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). Associated with its inhibitor, I kappaB, NF-kappaB resides as a...	[ "Characterization", "of", "a", "mutant", "cell", "line", "that", "does", "not", "activate", "NF", "-", "kappaB", "in", "response", "to", "multiple", "stimuli", ".", "\n", "Numerous", "genes", "required", "during", "the", "immune", "or", "inflammation", "respon...	[ "Entity", "Protein" ]
Toxicities , including thromboembolism is an outcome, overall survival is an outcome	892_task0	Sentence: Toxicities , including thromboembolism , and overall survival were similar . Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: outcome	[ "B-outcome", "I-outcome", "I-outcome", "I-outcome", "O", "O", "B-outcome", "I-outcome", "O", "O", "O" ]	Toxicities , including thromboembolism , and overall survival were similar .	[ "Toxicities", ",", "including", "thromboembolism", ",", "and", "overall", "survival", "were", "similar", "." ]	[ "outcome" ]
Toxicities , including thromboembolism is an outcome, overall survival is an outcome	892_task1	Sentence: Toxicities , including thromboembolism , and overall survival were similar . Instructions: please typing these entity words according to sentence: Toxicities , including thromboembolism, overall survival Options: outcome	[ "B-outcome", "I-outcome", "I-outcome", "I-outcome", "O", "O", "B-outcome", "I-outcome", "O", "O", "O" ]	Toxicities , including thromboembolism , and overall survival were similar .	[ "Toxicities", ",", "including", "thromboembolism", ",", "and", "overall", "survival", "were", "similar", "." ]	[ "outcome" ]
Toxicities , including thromboembolism, overall survival	892_task2	Sentence: Toxicities , including thromboembolism , and overall survival were similar . Instructions: please extract entity words from the input sentence	[ "B-outcome", "I-outcome", "I-outcome", "I-outcome", "O", "O", "B-outcome", "I-outcome", "O", "O", "O" ]	Toxicities , including thromboembolism , and overall survival were similar .	[ "Toxicities", ",", "including", "thromboembolism", ",", "and", "overall", "survival", "were", "similar", "." ]	[ "outcome" ]
hypertension is a Participant_Condition, reduced sodium intake is a Intervention_Physical, Dietary Approaches to Stop Hypertension ( DASH ) diet is a Intervention_Other, blood pressure ( BP ) is a Outcome_Physical, Adults is a Participant_Age, systolic BP 120 - 159 mm Hg and diastolic BP 80 - 95 mm Hg is a Participant_...	17841_task0	Sentence: Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control . The authors hypothesized that the Dietary Approaches to Stop Hypertension ( DASH ) diet and reduced sodium intake would control stage 1 hypertension and reduce high-normal blood pressure ( BP ) to ...	[ "O", "O", "O", "O", "O", "O", "O", "B-Participant_Condition", "O", "O", "B-Intervention_Physical", "I-Intervention_Physical", "I-Intervention_Physical", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Intervention_Other", "I-Intervention_Other", "I-Intervention...	Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control . The authors hypothesized that the Dietary Approaches to Stop Hypertension ( DASH ) diet and reduced sodium intake would control stage 1 hypertension and reduce high-normal blood pressure ( BP ) to optimal le...	[ "Effect", "of", "the", "dietary", "approaches", "to", "stop", "hypertension", "diet", "and", "reduced", "sodium", "intake", "on", "blood", "pressure", "control", ".", "The", "authors", "hypothesized", "that", "the", "Dietary", "Approaches", "to", "Stop", "Hypert...	[ "Participant_Condition", "Intervention_Other", "Intervention_Control", "Outcome_Physical", "Intervention_Educational", "Intervention_Physical", "Participant_Age" ]
hypertension is a Participant_Condition, reduced sodium intake is a Intervention_Physical, Dietary Approaches to Stop Hypertension ( DASH ) diet is a Intervention_Other, blood pressure ( BP ) is a Outcome_Physical, Adults is a Participant_Age, systolic BP 120 - 159 mm Hg and diastolic BP 80 - 95 mm Hg is a Participant_...	17841_task1	Sentence: Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control . The authors hypothesized that the Dietary Approaches to Stop Hypertension ( DASH ) diet and reduced sodium intake would control stage 1 hypertension and reduce high-normal blood pressure ( BP ) to ...	[ "O", "O", "O", "O", "O", "O", "O", "B-Participant_Condition", "O", "O", "B-Intervention_Physical", "I-Intervention_Physical", "I-Intervention_Physical", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Intervention_Other", "I-Intervention_Other", "I-Intervention...	Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control . The authors hypothesized that the Dietary Approaches to Stop Hypertension ( DASH ) diet and reduced sodium intake would control stage 1 hypertension and reduce high-normal blood pressure ( BP ) to optimal le...	[ "Effect", "of", "the", "dietary", "approaches", "to", "stop", "hypertension", "diet", "and", "reduced", "sodium", "intake", "on", "blood", "pressure", "control", ".", "The", "authors", "hypothesized", "that", "the", "Dietary", "Approaches", "to", "Stop", "Hypert...	[ "Participant_Condition", "Intervention_Other", "Intervention_Control", "Outcome_Physical", "Intervention_Educational", "Intervention_Physical", "Participant_Age" ]
hypertension, reduced sodium intake, Dietary Approaches to Stop Hypertension ( DASH ) diet, blood pressure ( BP ), Adults, systolic BP 120 - 159 mm Hg and diastolic BP 80 - 95 mm Hg, DASH diet, typical American ( control ) diet, BP control, increased BP control, maximum BP control rate, DASH / lower sodium diet, contro...	17841_task2	Sentence: Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control . The authors hypothesized that the Dietary Approaches to Stop Hypertension ( DASH ) diet and reduced sodium intake would control stage 1 hypertension and reduce high-normal blood pressure ( BP ) to ...	[ "O", "O", "O", "O", "O", "O", "O", "B-Participant_Condition", "O", "O", "B-Intervention_Physical", "I-Intervention_Physical", "I-Intervention_Physical", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Intervention_Other", "I-Intervention_Other", "I-Intervention...	Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control . The authors hypothesized that the Dietary Approaches to Stop Hypertension ( DASH ) diet and reduced sodium intake would control stage 1 hypertension and reduce high-normal blood pressure ( BP ) to optimal le...	[ "Effect", "of", "the", "dietary", "approaches", "to", "stop", "hypertension", "diet", "and", "reduced", "sodium", "intake", "on", "blood", "pressure", "control", ".", "The", "authors", "hypothesized", "that", "the", "Dietary", "Approaches", "to", "Stop", "Hypert...	[ "Participant_Condition", "Intervention_Other", "Intervention_Control", "Outcome_Physical", "Intervention_Educational", "Intervention_Physical", "Participant_Age" ]
CHH is a Gene, CHH is a Gene, CHH is a Gene, CHH is a Gene, CHH is a Gene	225_task0	Sentence: High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both f...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Gene", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...	High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both family seri...	[ "High", "-", "resolution", "linkage", "-", "disequilibrium", "mapping", "of", "the", "cartilage", "-", "hair", "hypoplasia", "gene", ".", "We", "recently", "assigned", "the", "gene", "for", "an", "autosomal", "recessive", "skeletal", "dysplasia", ",", "cartilage...	[ "Gene" ]
CHH is a Gene, CHH is a Gene, CHH is a Gene, CHH is a Gene, CHH is a Gene	225_task1	Sentence: High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both f...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Gene", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...	High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both family seri...	[ "High", "-", "resolution", "linkage", "-", "disequilibrium", "mapping", "of", "the", "cartilage", "-", "hair", "hypoplasia", "gene", ".", "We", "recently", "assigned", "the", "gene", "for", "an", "autosomal", "recessive", "skeletal", "dysplasia", ",", "cartilage...	[ "Gene" ]
CHH, CHH, CHH, CHH, CHH	225_task2	Sentence: High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both f...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Gene", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...	High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both family seri...	[ "High", "-", "resolution", "linkage", "-", "disequilibrium", "mapping", "of", "the", "cartilage", "-", "hair", "hypoplasia", "gene", ".", "We", "recently", "assigned", "the", "gene", "for", "an", "autosomal", "recessive", "skeletal", "dysplasia", ",", "cartilage...	[ "Gene" ]
urologic surgery is a Procedure	NCT02805504_inc_task0	Sentence: Patients undergoing urologic surgery. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: Procedure	[ "O", "O", "B-Procedure", "I-Procedure", "O", "O" ]	Patients undergoing urologic surgery.	[ "Patients", "undergoing", "urologic", "surgery", ".", "\n" ]	[ "Procedure" ]
urologic surgery is a Procedure	NCT02805504_inc_task1	Sentence: Patients undergoing urologic surgery. Instructions: please typing these entity words according to sentence: urologic surgery Options: Procedure	[ "O", "O", "B-Procedure", "I-Procedure", "O", "O" ]	Patients undergoing urologic surgery.	[ "Patients", "undergoing", "urologic", "surgery", ".", "\n" ]	[ "Procedure" ]
urologic surgery	NCT02805504_inc_task2	Sentence: Patients undergoing urologic surgery. Instructions: please extract entity words from the input sentence	[ "O", "O", "B-Procedure", "I-Procedure", "O", "O" ]	Patients undergoing urologic surgery.	[ "Patients", "undergoing", "urologic", "surgery", ".", "\n" ]	[ "Procedure" ]
Embryonenschutzgesetz is an umlsterm, Forschung is an umlsterm, Embryonen is an umlsterm, Deutschland is an umlsterm, Zellen is an umlsterm, Embryo is an umlsterm, Stammzellen is an umlsterm, Embryos is an umlsterm, Embryonenschutzgesetz is an umlsterm, selbst is an umlsterm, Embryo is an umlsterm, Zellen is an umlster...	Reproduktionsmedizin.90150159.ger.abstr_task0	Sentence: Das Embryonenschutzgesetz verbietet jegliche fremdnuetzige Forschung an und mit Embryonen . Damit ist in Deutschland die Entnahme von pluripotenten Zellen aus einem Embryo verboten . Die Gewinnung von embryonalen Stammzellen ( ES-Zellen ) aus Blastozysten erfolgt zu anderen Zwecken als zur Erhaltung des Embry...	[ "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "...	Das Embryonenschutzgesetz verbietet jegliche fremdnuetzige Forschung an und mit Embryonen . Damit ist in Deutschland die Entnahme von pluripotenten Zellen aus einem Embryo verboten . Die Gewinnung von embryonalen Stammzellen ( ES-Zellen ) aus Blastozysten erfolgt zu anderen Zwecken als zur Erhaltung des Embryos . Sie i...	[ "Das", "Embryonenschutzgesetz", "verbietet", "jegliche", "fremdnuetzige", "Forschung", "an", "und", "mit", "Embryonen", ".", "Damit", "ist", "in", "Deutschland", "die", "Entnahme", "von", "pluripotenten", "Zellen", "aus", "einem", "Embryo", "verboten", ".", "Die", ...	[ "umlsterm" ]
Embryonenschutzgesetz is an umlsterm, Forschung is an umlsterm, Embryonen is an umlsterm, Deutschland is an umlsterm, Zellen is an umlsterm, Embryo is an umlsterm, Stammzellen is an umlsterm, Embryos is an umlsterm, Embryonenschutzgesetz is an umlsterm, selbst is an umlsterm, Embryo is an umlsterm, Zellen is an umlster...	Reproduktionsmedizin.90150159.ger.abstr_task1	Sentence: Das Embryonenschutzgesetz verbietet jegliche fremdnuetzige Forschung an und mit Embryonen . Damit ist in Deutschland die Entnahme von pluripotenten Zellen aus einem Embryo verboten . Die Gewinnung von embryonalen Stammzellen ( ES-Zellen ) aus Blastozysten erfolgt zu anderen Zwecken als zur Erhaltung des Embry...	[ "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "...	Das Embryonenschutzgesetz verbietet jegliche fremdnuetzige Forschung an und mit Embryonen . Damit ist in Deutschland die Entnahme von pluripotenten Zellen aus einem Embryo verboten . Die Gewinnung von embryonalen Stammzellen ( ES-Zellen ) aus Blastozysten erfolgt zu anderen Zwecken als zur Erhaltung des Embryos . Sie i...	[ "Das", "Embryonenschutzgesetz", "verbietet", "jegliche", "fremdnuetzige", "Forschung", "an", "und", "mit", "Embryonen", ".", "Damit", "ist", "in", "Deutschland", "die", "Entnahme", "von", "pluripotenten", "Zellen", "aus", "einem", "Embryo", "verboten", ".", "Die", ...	[ "umlsterm" ]
Embryonenschutzgesetz, Forschung, Embryonen, Deutschland, Zellen, Embryo, Stammzellen, Embryos, Embryonenschutzgesetz, selbst, Embryo, Zellen, Zellkerntransfer, Eizellen, Stammzellen, Technik, Zellen, Menschen, Deutschland, Stammzellen, Gewebe, Feten, Gewebeentnahme, Verwendung, Zellen, Gewebe, Forschung, Stammzellen, ...	Reproduktionsmedizin.90150159.ger.abstr_task2	Sentence: Das Embryonenschutzgesetz verbietet jegliche fremdnuetzige Forschung an und mit Embryonen . Damit ist in Deutschland die Entnahme von pluripotenten Zellen aus einem Embryo verboten . Die Gewinnung von embryonalen Stammzellen ( ES-Zellen ) aus Blastozysten erfolgt zu anderen Zwecken als zur Erhaltung des Embry...	[ "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "...	Das Embryonenschutzgesetz verbietet jegliche fremdnuetzige Forschung an und mit Embryonen . Damit ist in Deutschland die Entnahme von pluripotenten Zellen aus einem Embryo verboten . Die Gewinnung von embryonalen Stammzellen ( ES-Zellen ) aus Blastozysten erfolgt zu anderen Zwecken als zur Erhaltung des Embryos . Sie i...	[ "Das", "Embryonenschutzgesetz", "verbietet", "jegliche", "fremdnuetzige", "Forschung", "an", "und", "mit", "Embryonen", ".", "Damit", "ist", "in", "Deutschland", "die", "Entnahme", "von", "pluripotenten", "Zellen", "aus", "einem", "Embryo", "verboten", ".", "Die", ...	[ "umlsterm" ]
neurotoxicity is a ADVERSE	example-381_task0	Sentence: Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Environmental and occupational exposure to lead (Pb) remains to be a major public health issue. The purpose of this cross-se...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Environmental and occupational exposure to lead (Pb) remains to be a major public health issue. The purpose of this cross-sectional st...	[ "Evidence", "for", "altered", "hippocampal", "volume", "and", "brain", "metabolites", "in", "workers", "occupationally", "exposed", "to", "lead", ":", "a", "study", "by", "magnetic", "resonance", "imaging", "and", "(", "1)H", "magnetic", "resonance", "spectroscopy...	[ "ADVERSE" ]
neurotoxicity is a ADVERSE	example-381_task1	Sentence: Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Environmental and occupational exposure to lead (Pb) remains to be a major public health issue. The purpose of this cross-se...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Environmental and occupational exposure to lead (Pb) remains to be a major public health issue. The purpose of this cross-sectional st...	[ "Evidence", "for", "altered", "hippocampal", "volume", "and", "brain", "metabolites", "in", "workers", "occupationally", "exposed", "to", "lead", ":", "a", "study", "by", "magnetic", "resonance", "imaging", "and", "(", "1)H", "magnetic", "resonance", "spectroscopy...	[ "ADVERSE" ]
neurotoxicity	example-381_task2	Sentence: Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Environmental and occupational exposure to lead (Pb) remains to be a major public health issue. The purpose of this cross-se...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Environmental and occupational exposure to lead (Pb) remains to be a major public health issue. The purpose of this cross-sectional st...	[ "Evidence", "for", "altered", "hippocampal", "volume", "and", "brain", "metabolites", "in", "workers", "occupationally", "exposed", "to", "lead", ":", "a", "study", "by", "magnetic", "resonance", "imaging", "and", "(", "1)H", "magnetic", "resonance", "spectroscopy...	[ "ADVERSE" ]
alpha - UBF antibody is a reagent, UBF is a protein, rDNA is a DNA, FISH is an assay	1.0alpha7.train.1055_task0	Sentence: To demonstrate that the alpha-UBF antibody used here can specifically recognize UBF bound to rDNA, we performed combined immunofluorescence and FISH analysis of metaphase chromosomes isolated from Xenopus cells (Fig. 2). Instructions: please extract entities and their types from the input se...	[ "O", "O", "O", "O", "B-reagent", "I-reagent", "I-reagent", "I-reagent", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "B-DNA", "O", "O", "O", "O", "O", "O", "O", "B-assay", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	To demonstrate that the alpha-UBF antibody used here can specifically recognize UBF bound to rDNA, we performed combined immunofluorescence and FISH analysis of metaphase chromosomes isolated from Xenopus cells (Fig. 2).	[ "To", "demonstrate", "that", "the", "alpha", "-", "UBF", "antibody", "used", "here", "can", "specifically", "recognize", " ", "UBF", "bound", "to", " ", "rDNA", ",", "we", "performed", "combined", "immunofluorescence", "and", " ", "FISH", "analysis", "of", "...	[ "reagent", "DNA", "assay", "protein" ]
alpha - UBF antibody is a reagent, UBF is a protein, rDNA is a DNA, FISH is an assay	1.0alpha7.train.1055_task1	Sentence: To demonstrate that the alpha-UBF antibody used here can specifically recognize UBF bound to rDNA, we performed combined immunofluorescence and FISH analysis of metaphase chromosomes isolated from Xenopus cells (Fig. 2). Instructions: please typing these entity words according to sentence: a...	[ "O", "O", "O", "O", "B-reagent", "I-reagent", "I-reagent", "I-reagent", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "B-DNA", "O", "O", "O", "O", "O", "O", "O", "B-assay", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	To demonstrate that the alpha-UBF antibody used here can specifically recognize UBF bound to rDNA, we performed combined immunofluorescence and FISH analysis of metaphase chromosomes isolated from Xenopus cells (Fig. 2).	[ "To", "demonstrate", "that", "the", "alpha", "-", "UBF", "antibody", "used", "here", "can", "specifically", "recognize", " ", "UBF", "bound", "to", " ", "rDNA", ",", "we", "performed", "combined", "immunofluorescence", "and", " ", "FISH", "analysis", "of", "...	[ "reagent", "DNA", "assay", "protein" ]
alpha - UBF antibody, UBF, rDNA, FISH	1.0alpha7.train.1055_task2	Sentence: To demonstrate that the alpha-UBF antibody used here can specifically recognize UBF bound to rDNA, we performed combined immunofluorescence and FISH analysis of metaphase chromosomes isolated from Xenopus cells (Fig. 2). Instructions: please extract entity words from the input sentence ...	[ "O", "O", "O", "O", "B-reagent", "I-reagent", "I-reagent", "I-reagent", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "B-DNA", "O", "O", "O", "O", "O", "O", "O", "B-assay", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...	To demonstrate that the alpha-UBF antibody used here can specifically recognize UBF bound to rDNA, we performed combined immunofluorescence and FISH analysis of metaphase chromosomes isolated from Xenopus cells (Fig. 2).	[ "To", "demonstrate", "that", "the", "alpha", "-", "UBF", "antibody", "used", "here", "can", "specifically", "recognize", " ", "UBF", "bound", "to", " ", "rDNA", ",", "we", "performed", "combined", "immunofluorescence", "and", " ", "FISH", "analysis", "of", "...	[ "reagent", "DNA", "assay", "protein" ]
Sp family members is a protein_family_or_group, promoter proximal repeat is a DNA_domain_or_region, HTLV - I enhancer is a DNA_domain_or_region	62654_task0	Sentence: Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: protein_family_or_group, DNA_domain_or_region	[ "B-protein_family_or_group", "I-protein_family_or_group", "I-protein_family_or_group", "O", "O", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain...	Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer.	[ "Sp", "family", "members", "preferentially", "interact", "with", "the", "promoter", "proximal", "repeat", "within", "the", "HTLV", "-", "I", "enhancer", "." ]	[ "cell_type", "other_name", "(AND polynucleotide polynucleotide)", "virus", "DNA_domain_or_region", "", "cell_line", "protein_family_or_group", "protein_complex", "(AND other_name other_name)", "protein_molecule" ]
Sp family members is a protein_family_or_group, promoter proximal repeat is a DNA_domain_or_region, HTLV - I enhancer is a DNA_domain_or_region	62654_task1	Sentence: Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer. Instructions: please typing these entity words according to sentence: Sp family members, promoter proximal repeat, HTLV - I enhancer Options: protein_family_or_group, DNA_domain_or_r...	[ "B-protein_family_or_group", "I-protein_family_or_group", "I-protein_family_or_group", "O", "O", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain...	Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer.	[ "Sp", "family", "members", "preferentially", "interact", "with", "the", "promoter", "proximal", "repeat", "within", "the", "HTLV", "-", "I", "enhancer", "." ]	[ "cell_type", "other_name", "(AND polynucleotide polynucleotide)", "virus", "DNA_domain_or_region", "", "cell_line", "protein_family_or_group", "protein_complex", "(AND other_name other_name)", "protein_molecule" ]
Sp family members, promoter proximal repeat, HTLV - I enhancer	62654_task2	Sentence: Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer. Instructions: please extract entity words from the input sentence	[ "B-protein_family_or_group", "I-protein_family_or_group", "I-protein_family_or_group", "O", "O", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain...	Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer.	[ "Sp", "family", "members", "preferentially", "interact", "with", "the", "promoter", "proximal", "repeat", "within", "the", "HTLV", "-", "I", "enhancer", "." ]	[ "cell_type", "other_name", "(AND polynucleotide polynucleotide)", "virus", "DNA_domain_or_region", "", "cell_line", "protein_family_or_group", "protein_complex", "(AND other_name other_name)", "protein_molecule" ]
Surgery is an umlsterm, therapeutic is an umlsterm, treatment is an umlsterm, tumors is an umlsterm, head is an umlsterm, neck is an umlsterm, dates is an umlsterm, lymph node dissection is an umlsterm, surgery is an umlsterm, plastic is an umlsterm, reconstructive surgery is an umlsterm, surgical is an umlsterm, patie...	MundKieferGesichtschirurgie.0004s142.eng.abstr_task0	Sentence: Surgery is still the primary therapeutic approach in treatment of tumors in the head and neck area , dating back to the early nineteenth century . More than 150 years ago , hemimaxillectomies and mandibular resections as well as hemiglossectomies were already performed by leading surgeons . The block principl...	[ "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...	Surgery is still the primary therapeutic approach in treatment of tumors in the head and neck area , dating back to the early nineteenth century . More than 150 years ago , hemimaxillectomies and mandibular resections as well as hemiglossectomies were already performed by leading surgeons . The block principle we are n...	[ "Surgery", "is", "still", "the", "primary", "therapeutic", "approach", "in", "treatment", "of", "tumors", "in", "the", "head", "and", "neck", "area", ",", "dating", "back", "to", "the", "early", "nineteenth", "century", ".", "More", "than", "150", "years", ...	[ "umlsterm" ]
Surgery is an umlsterm, therapeutic is an umlsterm, treatment is an umlsterm, tumors is an umlsterm, head is an umlsterm, neck is an umlsterm, dates is an umlsterm, lymph node dissection is an umlsterm, surgery is an umlsterm, plastic is an umlsterm, reconstructive surgery is an umlsterm, surgical is an umlsterm, patie...	MundKieferGesichtschirurgie.0004s142.eng.abstr_task1	Sentence: Surgery is still the primary therapeutic approach in treatment of tumors in the head and neck area , dating back to the early nineteenth century . More than 150 years ago , hemimaxillectomies and mandibular resections as well as hemiglossectomies were already performed by leading surgeons . The block principl...	[ "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...	Surgery is still the primary therapeutic approach in treatment of tumors in the head and neck area , dating back to the early nineteenth century . More than 150 years ago , hemimaxillectomies and mandibular resections as well as hemiglossectomies were already performed by leading surgeons . The block principle we are n...	[ "Surgery", "is", "still", "the", "primary", "therapeutic", "approach", "in", "treatment", "of", "tumors", "in", "the", "head", "and", "neck", "area", ",", "dating", "back", "to", "the", "early", "nineteenth", "century", ".", "More", "than", "150", "years", ...	[ "umlsterm" ]
Surgery, therapeutic, treatment, tumors, head, neck, dates, lymph node dissection, surgery, plastic, reconstructive surgery, surgical, patients, development, reconstructive surgery, stages, secondary, flaps, The change, skin, flaps, flaps, tissue, transfer, bone grafting, bone grafting, bone, transfer, donor, five - ye...	MundKieferGesichtschirurgie.0004s142.eng.abstr_task2	Sentence: Surgery is still the primary therapeutic approach in treatment of tumors in the head and neck area , dating back to the early nineteenth century . More than 150 years ago , hemimaxillectomies and mandibular resections as well as hemiglossectomies were already performed by leading surgeons . The block principl...	[ "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...	Surgery is still the primary therapeutic approach in treatment of tumors in the head and neck area , dating back to the early nineteenth century . More than 150 years ago , hemimaxillectomies and mandibular resections as well as hemiglossectomies were already performed by leading surgeons . The block principle we are n...	[ "Surgery", "is", "still", "the", "primary", "therapeutic", "approach", "in", "treatment", "of", "tumors", "in", "the", "head", "and", "neck", "area", ",", "dating", "back", "to", "the", "early", "nineteenth", "century", ".", "More", "than", "150", "years", ...	[ "umlsterm" ]
CCL3 is a GENE-Y, CCR1 is a GENE-Y	23059626_task0	Sentence: The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: GENE-Y	[ "O", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice.	[ "The", "effect", "of", "CCL3", "and", "CCR1", "in", "bone", "remodeling", "induced", "by", "mechanical", "loading", "during", "orthodontic", "tooth", "movement", "in", "mice", "." ]	[ "GENE-Y", "GENE-N", "CHEMICAL" ]
CCL3 is a GENE-Y, CCR1 is a GENE-Y	23059626_task1	Sentence: The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice. Instructions: please typing these entity words according to sentence: CCL3, CCR1 Options: GENE-Y	[ "O", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice.	[ "The", "effect", "of", "CCL3", "and", "CCR1", "in", "bone", "remodeling", "induced", "by", "mechanical", "loading", "during", "orthodontic", "tooth", "movement", "in", "mice", "." ]	[ "GENE-Y", "GENE-N", "CHEMICAL" ]
CCL3, CCR1	23059626_task2	Sentence: The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice. Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice.	[ "The", "effect", "of", "CCL3", "and", "CCR1", "in", "bone", "remodeling", "induced", "by", "mechanical", "loading", "during", "orthodontic", "tooth", "movement", "in", "mice", "." ]	[ "GENE-Y", "GENE-N", "CHEMICAL" ]
Ramipril is an intervention, progression is an outcome	512_task0	Sentence: Ramipril reduced the risk for any progression ( OR , 0.87 ; 95 % CI , 0.78 to 0.97 ; P = 0.0146 ) . Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: intervention, outcome	[ "B-intervention", "O", "O", "O", "O", "O", "B-outcome", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	Ramipril reduced the risk for any progression ( OR , 0.87 ; 95 % CI , 0.78 to 0.97 ; P = 0.0146 ) .	[ "Ramipril", "reduced", "the", "risk", "for", "any", "progression", "(", "OR", ",", "0.87", ";", "95", "%", "CI", ",", "0.78", "to", "0.97", ";", "P", "=", "0.0146", ")", "." ]	[ "outcome", "intervention" ]
Ramipril is an intervention, progression is an outcome	512_task1	Sentence: Ramipril reduced the risk for any progression ( OR , 0.87 ; 95 % CI , 0.78 to 0.97 ; P = 0.0146 ) . Instructions: please typing these entity words according to sentence: Ramipril, progression Options: intervention, outcome	[ "B-intervention", "O", "O", "O", "O", "O", "B-outcome", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	Ramipril reduced the risk for any progression ( OR , 0.87 ; 95 % CI , 0.78 to 0.97 ; P = 0.0146 ) .	[ "Ramipril", "reduced", "the", "risk", "for", "any", "progression", "(", "OR", ",", "0.87", ";", "95", "%", "CI", ",", "0.78", "to", "0.97", ";", "P", "=", "0.0146", ")", "." ]	[ "outcome", "intervention" ]
Ramipril, progression	512_task2	Sentence: Ramipril reduced the risk for any progression ( OR , 0.87 ; 95 % CI , 0.78 to 0.97 ; P = 0.0146 ) . Instructions: please extract entity words from the input sentence	[ "B-intervention", "O", "O", "O", "O", "O", "B-outcome", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]	Ramipril reduced the risk for any progression ( OR , 0.87 ; 95 % CI , 0.78 to 0.97 ; P = 0.0146 ) .	[ "Ramipril", "reduced", "the", "risk", "for", "any", "progression", "(", "OR", ",", "0.87", ";", "95", "%", "CI", ",", "0.78", "to", "0.97", ";", "P", "=", "0.0146", ")", "." ]	[ "outcome", "intervention" ]
cisplatin is a CHEMICAL	16876126_task0	Sentence: RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: CHEMICAL	[ "O", "O", "O", "O", "O", "O", "O", "B-CHEMICAL", "O", "O", "O", "O", "O", "O" ]	RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells.	[ "RNA", "interference", "-", "triggered", "reversal", "of", "ABCC2-dependent", "cisplatin", "resistance", "in", "human", "cancer", "cells", "." ]	[ "GENE-N", "CHEMICAL", "GENE-Y" ]
cisplatin is a CHEMICAL	16876126_task1	Sentence: RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells. Instructions: please typing these entity words according to sentence: cisplatin Options: CHEMICAL	[ "O", "O", "O", "O", "O", "O", "O", "B-CHEMICAL", "O", "O", "O", "O", "O", "O" ]	RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells.	[ "RNA", "interference", "-", "triggered", "reversal", "of", "ABCC2-dependent", "cisplatin", "resistance", "in", "human", "cancer", "cells", "." ]	[ "GENE-N", "CHEMICAL", "GENE-Y" ]
cisplatin	16876126_task2	Sentence: RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells. Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "O", "O", "O", "O", "B-CHEMICAL", "O", "O", "O", "O", "O", "O" ]	RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells.	[ "RNA", "interference", "-", "triggered", "reversal", "of", "ABCC2-dependent", "cisplatin", "resistance", "in", "human", "cancer", "cells", "." ]	[ "GENE-N", "CHEMICAL", "GENE-Y" ]
Mn SOD is a Protein, Mn superoxide dismutase is a Protein, Cu , Zn SOD is a Protein, catalase is a Protein, Mn SOD is a Protein, human monocyte nuclear factor - kappaB is a Entity, Mn SOD is a Protein, tumor necrosis factor - alpha is a Protein, macrophage inflammatory protein-1alpha is a Protein, Mn SOD is a Protein, ...	105_task0	Sentence: Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relatio...	[ "O", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", ...	Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relationship and ...	[ "Induction", "of", "Mn", "SOD", "in", "human", "monocytes", "without", "inflammatory", "cytokine", "production", "by", "a", "mutant", "endotoxin", ".", "\n", "Endotoxin", "selectively", "induces", "monocyte", "Mn", "superoxide", "dismutase", "(", "SOD", ")", "wi...	[ "Protein", "Entity" ]
Mn SOD is a Protein, Mn superoxide dismutase is a Protein, Cu , Zn SOD is a Protein, catalase is a Protein, Mn SOD is a Protein, human monocyte nuclear factor - kappaB is a Entity, Mn SOD is a Protein, tumor necrosis factor - alpha is a Protein, macrophage inflammatory protein-1alpha is a Protein, Mn SOD is a Protein, ...	105_task1	Sentence: Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relatio...	[ "O", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", ...	Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relationship and ...	[ "Induction", "of", "Mn", "SOD", "in", "human", "monocytes", "without", "inflammatory", "cytokine", "production", "by", "a", "mutant", "endotoxin", ".", "\n", "Endotoxin", "selectively", "induces", "monocyte", "Mn", "superoxide", "dismutase", "(", "SOD", ")", "wi...	[ "Protein", "Entity" ]
Mn SOD, Mn superoxide dismutase, Cu , Zn SOD, catalase, Mn SOD, human monocyte nuclear factor - kappaB, Mn SOD, tumor necrosis factor - alpha, macrophage inflammatory protein-1alpha, Mn SOD, Mn SOD, tumor necrosis factor - alpha	105_task2	Sentence: Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relatio...	[ "O", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", ...	Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relationship and ...	[ "Induction", "of", "Mn", "SOD", "in", "human", "monocytes", "without", "inflammatory", "cytokine", "production", "by", "a", "mutant", "endotoxin", ".", "\n", "Endotoxin", "selectively", "induces", "monocyte", "Mn", "superoxide", "dismutase", "(", "SOD", ")", "wi...	[ "Protein", "Entity" ]
Surgery is an umlsterm, hyperparathyroidism is an umlsterm, standard is an umlsterm, therapy is an umlsterm, frequency is an umlsterm, testing is an umlsterm, surgery is an umlsterm, evaluation is an umlsterm, surgical is an umlsterm, safety is an umlsterm, retrospective is an umlsterm, analysis is an umlsterm, patient...	DerChirurg.70680141.eng.abstr_task0	Sentence: Surgery for symptomatic hyperparathyroidism remains the standard therapy . Asymptomatic primary hyperparathyroidsm ( pHPT ) is being diagnosed with increasing frequency owing to broad serum testing . Indications for surgery in this setting are controversial . For evaluation of surgical safety we performed a r...	[ "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "...	Surgery for symptomatic hyperparathyroidism remains the standard therapy . Asymptomatic primary hyperparathyroidsm ( pHPT ) is being diagnosed with increasing frequency owing to broad serum testing . Indications for surgery in this setting are controversial . For evaluation of surgical safety we performed a retrospecti...	[ "Surgery", "for", "symptomatic", "hyperparathyroidism", "remains", "the", "standard", "therapy", ".", "Asymptomatic", "primary", "hyperparathyroidsm", "(", "pHPT", ")", "is", "being", "diagnosed", "with", "increasing", "frequency", "owing", "to", "broad", "serum", "...	[ "umlsterm" ]
Surgery is an umlsterm, hyperparathyroidism is an umlsterm, standard is an umlsterm, therapy is an umlsterm, frequency is an umlsterm, testing is an umlsterm, surgery is an umlsterm, evaluation is an umlsterm, surgical is an umlsterm, safety is an umlsterm, retrospective is an umlsterm, analysis is an umlsterm, patient...	DerChirurg.70680141.eng.abstr_task1	Sentence: Surgery for symptomatic hyperparathyroidism remains the standard therapy . Asymptomatic primary hyperparathyroidsm ( pHPT ) is being diagnosed with increasing frequency owing to broad serum testing . Indications for surgery in this setting are controversial . For evaluation of surgical safety we performed a r...	[ "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "...	Surgery for symptomatic hyperparathyroidism remains the standard therapy . Asymptomatic primary hyperparathyroidsm ( pHPT ) is being diagnosed with increasing frequency owing to broad serum testing . Indications for surgery in this setting are controversial . For evaluation of surgical safety we performed a retrospecti...	[ "Surgery", "for", "symptomatic", "hyperparathyroidism", "remains", "the", "standard", "therapy", ".", "Asymptomatic", "primary", "hyperparathyroidsm", "(", "pHPT", ")", "is", "being", "diagnosed", "with", "increasing", "frequency", "owing", "to", "broad", "serum", "...	[ "umlsterm" ]
Surgery, hyperparathyroidism, standard, therapy, frequency, testing, surgery, evaluation, surgical, safety, retrospective, analysis, patients, patients, patients, patients, female, age, patients, sonography, adenoma, catheterization, analysis, patients, patients, procedures, ultrasound, catheterization, Postoperative, ...	DerChirurg.70680141.eng.abstr_task2	Sentence: Surgery for symptomatic hyperparathyroidism remains the standard therapy . Asymptomatic primary hyperparathyroidsm ( pHPT ) is being diagnosed with increasing frequency owing to broad serum testing . Indications for surgery in this setting are controversial . For evaluation of surgical safety we performed a r...	[ "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "...	Surgery for symptomatic hyperparathyroidism remains the standard therapy . Asymptomatic primary hyperparathyroidsm ( pHPT ) is being diagnosed with increasing frequency owing to broad serum testing . Indications for surgery in this setting are controversial . For evaluation of surgical safety we performed a retrospecti...	[ "Surgery", "for", "symptomatic", "hyperparathyroidism", "remains", "the", "standard", "therapy", ".", "Asymptomatic", "primary", "hyperparathyroidsm", "(", "pHPT", ")", "is", "being", "diagnosed", "with", "increasing", "frequency", "owing", "to", "broad", "serum", "...	[ "umlsterm" ]
Wachstum is an umlsterm, Schaedelkorrekturen is an umlsterm, Kraniosynostosen is an umlsterm, Schaedelkonfiguration is an umlsterm, Krankengut is an umlsterm, Kindern is an umlsterm, maennliche is an umlsterm, weibliche is an umlsterm, syndromale is an umlsterm, Kraniosynostosen is an umlsterm, Kraniosynostose is an um...	MundKieferGesichtschirurgie.8002s049.ger.abstr_task0	Sentence: Ziel der prospektiven Studie war es zu untersuchen , ob das postoperative Wachstum nach Schaedelkorrekturen bei Kraniosynostosen perzentilengerecht im Verhaeltnis zu einem Normalkollektiv weiterverlaeuft , da durch die Operation eine normale " Schaedelkonfiguration " erreicht wird . Das Krankengut setzte sich...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", ...	Ziel der prospektiven Studie war es zu untersuchen , ob das postoperative Wachstum nach Schaedelkorrekturen bei Kraniosynostosen perzentilengerecht im Verhaeltnis zu einem Normalkollektiv weiterverlaeuft , da durch die Operation eine normale " Schaedelkonfiguration " erreicht wird . Das Krankengut setzte sich aus 71 Ki...	[ "Ziel", "der", "prospektiven", "Studie", "war", "es", "zu", "untersuchen", ",", "ob", "das", "postoperative", "Wachstum", "nach", "Schaedelkorrekturen", "bei", "Kraniosynostosen", "perzentilengerecht", "im", "Verhaeltnis", "zu", "einem", "Normalkollektiv", "weiterverlae...	[ "umlsterm" ]
Wachstum is an umlsterm, Schaedelkorrekturen is an umlsterm, Kraniosynostosen is an umlsterm, Schaedelkonfiguration is an umlsterm, Krankengut is an umlsterm, Kindern is an umlsterm, maennliche is an umlsterm, weibliche is an umlsterm, syndromale is an umlsterm, Kraniosynostosen is an umlsterm, Kraniosynostose is an um...	MundKieferGesichtschirurgie.8002s049.ger.abstr_task1	Sentence: Ziel der prospektiven Studie war es zu untersuchen , ob das postoperative Wachstum nach Schaedelkorrekturen bei Kraniosynostosen perzentilengerecht im Verhaeltnis zu einem Normalkollektiv weiterverlaeuft , da durch die Operation eine normale " Schaedelkonfiguration " erreicht wird . Das Krankengut setzte sich...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", ...	Ziel der prospektiven Studie war es zu untersuchen , ob das postoperative Wachstum nach Schaedelkorrekturen bei Kraniosynostosen perzentilengerecht im Verhaeltnis zu einem Normalkollektiv weiterverlaeuft , da durch die Operation eine normale " Schaedelkonfiguration " erreicht wird . Das Krankengut setzte sich aus 71 Ki...	[ "Ziel", "der", "prospektiven", "Studie", "war", "es", "zu", "untersuchen", ",", "ob", "das", "postoperative", "Wachstum", "nach", "Schaedelkorrekturen", "bei", "Kraniosynostosen", "perzentilengerecht", "im", "Verhaeltnis", "zu", "einem", "Normalkollektiv", "weiterverlae...	[ "umlsterm" ]
Wachstum, Schaedelkorrekturen, Kraniosynostosen, Schaedelkonfiguration, Krankengut, Kindern, maennliche, weibliche, syndromale, Kraniosynostosen, Kraniosynostose, Kopfumfang, Kraniotomie, Bandes, Kraniosynostosen, Patienten, Patienten, Patient, Kraniosynostosen, Patienten, Patienten, Patient, Kraniosynostosen, Wachstum...	MundKieferGesichtschirurgie.8002s049.ger.abstr_task2	Sentence: Ziel der prospektiven Studie war es zu untersuchen , ob das postoperative Wachstum nach Schaedelkorrekturen bei Kraniosynostosen perzentilengerecht im Verhaeltnis zu einem Normalkollektiv weiterverlaeuft , da durch die Operation eine normale " Schaedelkonfiguration " erreicht wird . Das Krankengut setzte sich...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", ...	Ziel der prospektiven Studie war es zu untersuchen , ob das postoperative Wachstum nach Schaedelkorrekturen bei Kraniosynostosen perzentilengerecht im Verhaeltnis zu einem Normalkollektiv weiterverlaeuft , da durch die Operation eine normale " Schaedelkonfiguration " erreicht wird . Das Krankengut setzte sich aus 71 Ki...	[ "Ziel", "der", "prospektiven", "Studie", "war", "es", "zu", "untersuchen", ",", "ob", "das", "postoperative", "Wachstum", "nach", "Schaedelkorrekturen", "bei", "Kraniosynostosen", "perzentilengerecht", "im", "Verhaeltnis", "zu", "einem", "Normalkollektiv", "weiterverlae...	[ "umlsterm" ]
actin is a protein-family	1.0alpha7.train.98_task0	Sentence: This is contrary to what one would expect if high ionic strength decreases the effect of the mutation on the binding of the regulatory complex to actin. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: protein-famil...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein-family", "O" ]	This is contrary to what one would expect if high ionic strength decreases the effect of the mutation on the binding of the regulatory complex to actin.	[ "This", "is", "contrary", "to", "what", "one", "would", "expect", "if", "high", "ionic", "strength", "decreases", "the", "effect", "of", "the", "mutation", "on", "the", "binding", "of", "the", "regulatory", "complex", "to", "actin", "." ]	[ "protein-family" ]
actin is a protein-family	1.0alpha7.train.98_task1	Sentence: This is contrary to what one would expect if high ionic strength decreases the effect of the mutation on the binding of the regulatory complex to actin. Instructions: please typing these entity words according to sentence: actin Options: protein-family	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein-family", "O" ]	This is contrary to what one would expect if high ionic strength decreases the effect of the mutation on the binding of the regulatory complex to actin.	[ "This", "is", "contrary", "to", "what", "one", "would", "expect", "if", "high", "ionic", "strength", "decreases", "the", "effect", "of", "the", "mutation", "on", "the", "binding", "of", "the", "regulatory", "complex", "to", "actin", "." ]	[ "protein-family" ]
actin	1.0alpha7.train.98_task2	Sentence: This is contrary to what one would expect if high ionic strength decreases the effect of the mutation on the binding of the regulatory complex to actin. Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein-family", "O" ]	This is contrary to what one would expect if high ionic strength decreases the effect of the mutation on the binding of the regulatory complex to actin.	[ "This", "is", "contrary", "to", "what", "one", "would", "expect", "if", "high", "ionic", "strength", "decreases", "the", "effect", "of", "the", "mutation", "on", "the", "binding", "of", "the", "regulatory", "complex", "to", "actin", "." ]	[ "protein-family" ]
AT1 receptor is a GENE-Y, BDNF is a GENE-Y	23211364_task0	Sentence: AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: GENE-Y	[ "B-GENE-Y", "I-GENE-Y", "O", "O", "O", "O", "O", "O", "O", "B-GENE-Y", "O", "O", "O", "O" ]	AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.	[ "AT1", "receptor", "antagonism", "is", "proangiogenic", "in", "the", "brain", ":", "BDNF", "a", "novel", "mediator", "." ]	[ "GENE-Y", "GENE-N", "CHEMICAL" ]
AT1 receptor is a GENE-Y, BDNF is a GENE-Y	23211364_task1	Sentence: AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. Instructions: please typing these entity words according to sentence: AT1 receptor, BDNF Options: GENE-Y	[ "B-GENE-Y", "I-GENE-Y", "O", "O", "O", "O", "O", "O", "O", "B-GENE-Y", "O", "O", "O", "O" ]	AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.	[ "AT1", "receptor", "antagonism", "is", "proangiogenic", "in", "the", "brain", ":", "BDNF", "a", "novel", "mediator", "." ]	[ "GENE-Y", "GENE-N", "CHEMICAL" ]
AT1 receptor, BDNF	23211364_task2	Sentence: AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. Instructions: please extract entity words from the input sentence	[ "B-GENE-Y", "I-GENE-Y", "O", "O", "O", "O", "O", "O", "O", "B-GENE-Y", "O", "O", "O", "O" ]	AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.	[ "AT1", "receptor", "antagonism", "is", "proangiogenic", "in", "the", "brain", ":", "BDNF", "a", "novel", "mediator", "." ]	[ "GENE-Y", "GENE-N", "CHEMICAL" ]
Paola is a NOMBRE_SUJETO_ASISTENCIA, Barba Vega is a NOMBRE_SUJETO_ASISTENCIA, 4387459 is a ID_SUJETO_ASISTENCIA, 83 56740786 47 is a ID_ASEGURAMIENTO, Calle Puchaicela , 34 is a CALLE, Madrid is a TERRITORIO, 31250 is a TERRITORIO, 21/07/1981 is a FECHAS, España is a PAIS, 34 años is a EDAD_SUJETO_ASISTENCIA, 10/11/20...	359_task0	Sentence: Datos del paciente. Nombre: Paola. Apellidos: Barba Vega. NHC: 4387459. NASS: 83 56740786 47. Domicilio: Calle Puchaicela, 34 . Localidad/ Provincia: Madrid. CP: 31250. Datos asistenciales. Fecha de nacimiento: 21/07/1981. País de nacimiento: España. Edad: 34 años Sexo: M. Fecha de Ingreso: 10/11/2015. Médico...	[ "O", "O", "O", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "I-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_ASEGURAMIENTO", "I-ID_ASEGURAMIENTO", "I-ID_ASEGU...	Datos del paciente. Nombre: Paola. Apellidos: Barba Vega. NHC: 4387459. NASS: 83 56740786 47. Domicilio: Calle Puchaicela, 34 . Localidad/ Provincia: Madrid. CP: 31250. Datos asistenciales. Fecha de nacimiento: 21/07/1981. País de nacimiento: España. Edad: 34 años Sexo: M. Fecha de Ingreso: 10/11/2015. Médico: Ana M. C...	[ "Datos", "del", "paciente", ".", "\n", "Nombre", ":", "Paola", ".", "\n", "Apellidos", ":", "Barba", "Vega", ".", "\n", "NHC", ":", "4387459", ".", "\n", "NASS", ":", "83", "56740786", "47", ".", "\n", "Domicilio", ":", "Calle", "Puchaicela", ",", "3...	[ "CALLE", "HOSPITAL", "NOMBRE_PERSONAL_SANITARIO", "ID_ASEGURAMIENTO", "ID_TITULACION_PERSONAL_SANITARIO", "NUMERO_TELEFONO", "FECHAS", "NOMBRE_SUJETO_ASISTENCIA", "TERRITORIO", "EDAD_SUJETO_ASISTENCIA", "ID_SUJETO_ASISTENCIA", "PAIS", "SEXO_SUJETO_ASISTENCIA" ]
Paola is a NOMBRE_SUJETO_ASISTENCIA, Barba Vega is a NOMBRE_SUJETO_ASISTENCIA, 4387459 is a ID_SUJETO_ASISTENCIA, 83 56740786 47 is a ID_ASEGURAMIENTO, Calle Puchaicela , 34 is a CALLE, Madrid is a TERRITORIO, 31250 is a TERRITORIO, 21/07/1981 is a FECHAS, España is a PAIS, 34 años is a EDAD_SUJETO_ASISTENCIA, 10/11/20...	359_task1	Sentence: Datos del paciente. Nombre: Paola. Apellidos: Barba Vega. NHC: 4387459. NASS: 83 56740786 47. Domicilio: Calle Puchaicela, 34 . Localidad/ Provincia: Madrid. CP: 31250. Datos asistenciales. Fecha de nacimiento: 21/07/1981. País de nacimiento: España. Edad: 34 años Sexo: M. Fecha de Ingreso: 10/11/2015. Médico...	[ "O", "O", "O", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "I-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_ASEGURAMIENTO", "I-ID_ASEGURAMIENTO", "I-ID_ASEGU...	Datos del paciente. Nombre: Paola. Apellidos: Barba Vega. NHC: 4387459. NASS: 83 56740786 47. Domicilio: Calle Puchaicela, 34 . Localidad/ Provincia: Madrid. CP: 31250. Datos asistenciales. Fecha de nacimiento: 21/07/1981. País de nacimiento: España. Edad: 34 años Sexo: M. Fecha de Ingreso: 10/11/2015. Médico: Ana M. C...	[ "Datos", "del", "paciente", ".", "\n", "Nombre", ":", "Paola", ".", "\n", "Apellidos", ":", "Barba", "Vega", ".", "\n", "NHC", ":", "4387459", ".", "\n", "NASS", ":", "83", "56740786", "47", ".", "\n", "Domicilio", ":", "Calle", "Puchaicela", ",", "3...	[ "CALLE", "HOSPITAL", "NOMBRE_PERSONAL_SANITARIO", "ID_ASEGURAMIENTO", "ID_TITULACION_PERSONAL_SANITARIO", "NUMERO_TELEFONO", "FECHAS", "NOMBRE_SUJETO_ASISTENCIA", "TERRITORIO", "EDAD_SUJETO_ASISTENCIA", "ID_SUJETO_ASISTENCIA", "PAIS", "SEXO_SUJETO_ASISTENCIA" ]
Paola, Barba Vega, 4387459, 83 56740786 47, Calle Puchaicela , 34, Madrid, 31250, 21/07/1981, España, 34 años, 10/11/2015, Ana M. Calvo Benito, 31 31 20250, Mujer, 34 años, Ana M. Calvo Benito, Hospital de Navarra, C/ Irunlarrea , 3, 31008, Pamplona, 848 422179	359_task2	Sentence: Datos del paciente. Nombre: Paola. Apellidos: Barba Vega. NHC: 4387459. NASS: 83 56740786 47. Domicilio: Calle Puchaicela, 34 . Localidad/ Provincia: Madrid. CP: 31250. Datos asistenciales. Fecha de nacimiento: 21/07/1981. País de nacimiento: España. Edad: 34 años Sexo: M. Fecha de Ingreso: 10/11/2015. Médico...	[ "O", "O", "O", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "I-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_ASEGURAMIENTO", "I-ID_ASEGURAMIENTO", "I-ID_ASEGU...	Datos del paciente. Nombre: Paola. Apellidos: Barba Vega. NHC: 4387459. NASS: 83 56740786 47. Domicilio: Calle Puchaicela, 34 . Localidad/ Provincia: Madrid. CP: 31250. Datos asistenciales. Fecha de nacimiento: 21/07/1981. País de nacimiento: España. Edad: 34 años Sexo: M. Fecha de Ingreso: 10/11/2015. Médico: Ana M. C...	[ "Datos", "del", "paciente", ".", "\n", "Nombre", ":", "Paola", ".", "\n", "Apellidos", ":", "Barba", "Vega", ".", "\n", "NHC", ":", "4387459", ".", "\n", "NASS", ":", "83", "56740786", "47", ".", "\n", "Domicilio", ":", "Calle", "Puchaicela", ",", "3...	[ "CALLE", "HOSPITAL", "NOMBRE_PERSONAL_SANITARIO", "ID_ASEGURAMIENTO", "ID_TITULACION_PERSONAL_SANITARIO", "NUMERO_TELEFONO", "FECHAS", "NOMBRE_SUJETO_ASISTENCIA", "TERRITORIO", "EDAD_SUJETO_ASISTENCIA", "ID_SUJETO_ASISTENCIA", "PAIS", "SEXO_SUJETO_ASISTENCIA" ]
Stammzellen is an umlsterm, Wiederherstellung is an umlsterm, Haematopoese is an umlsterm, Therapie is an umlsterm, Behandlung is an umlsterm, Mangelsyndrome is an umlsterm, Stoffwechselkrankheiten is an umlsterm, Transportvehikel is an umlsterm, Gentherapie is an umlsterm, Stammzellen is an umlsterm, Knochenmark is an...	Bundesgesundheitsblatt.90420105.ger.abstr_task0	Sentence: Praeparationen haematopoetischer Stammzellen bieten prinzipiell eine unendliche Vielfalt klinischer Anwendungsmoeglichkeiten und Zukunftsperspektiven . Sie sind die Basis fuer Stammzelltransplantationen , d.h. fuer die Wiederherstellung der Haematopoese nach hochdosierter zytotoxischer Therapie und bilden die...	[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-um...	Praeparationen haematopoetischer Stammzellen bieten prinzipiell eine unendliche Vielfalt klinischer Anwendungsmoeglichkeiten und Zukunftsperspektiven . Sie sind die Basis fuer Stammzelltransplantationen , d.h. fuer die Wiederherstellung der Haematopoese nach hochdosierter zytotoxischer Therapie und bilden die Grundlage...	[ "Praeparationen", "haematopoetischer", "Stammzellen", "bieten", "prinzipiell", "eine", "unendliche", "Vielfalt", "klinischer", "Anwendungsmoeglichkeiten", "und", "Zukunftsperspektiven", ".", "Sie", "sind", "die", "Basis", "fuer", "Stammzelltransplantationen", ",", "d.h", "....	[ "umlsterm" ]
Stammzellen is an umlsterm, Wiederherstellung is an umlsterm, Haematopoese is an umlsterm, Therapie is an umlsterm, Behandlung is an umlsterm, Mangelsyndrome is an umlsterm, Stoffwechselkrankheiten is an umlsterm, Transportvehikel is an umlsterm, Gentherapie is an umlsterm, Stammzellen is an umlsterm, Knochenmark is an...	Bundesgesundheitsblatt.90420105.ger.abstr_task1	Sentence: Praeparationen haematopoetischer Stammzellen bieten prinzipiell eine unendliche Vielfalt klinischer Anwendungsmoeglichkeiten und Zukunftsperspektiven . Sie sind die Basis fuer Stammzelltransplantationen , d.h. fuer die Wiederherstellung der Haematopoese nach hochdosierter zytotoxischer Therapie und bilden die...	[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-um...	Praeparationen haematopoetischer Stammzellen bieten prinzipiell eine unendliche Vielfalt klinischer Anwendungsmoeglichkeiten und Zukunftsperspektiven . Sie sind die Basis fuer Stammzelltransplantationen , d.h. fuer die Wiederherstellung der Haematopoese nach hochdosierter zytotoxischer Therapie und bilden die Grundlage...	[ "Praeparationen", "haematopoetischer", "Stammzellen", "bieten", "prinzipiell", "eine", "unendliche", "Vielfalt", "klinischer", "Anwendungsmoeglichkeiten", "und", "Zukunftsperspektiven", ".", "Sie", "sind", "die", "Basis", "fuer", "Stammzelltransplantationen", ",", "d.h", "....	[ "umlsterm" ]
Stammzellen, Wiederherstellung, Haematopoese, Therapie, Behandlung, Mangelsyndrome, Stoffwechselkrankheiten, Transportvehikel, Gentherapie, Stammzellen, Knochenmark, Blut, Nabelschnurblut, Biologie, Stammzellen, Zulassung, Stammzellen, Arzneimittel, Person, Gebrauch	Bundesgesundheitsblatt.90420105.ger.abstr_task2	Sentence: Praeparationen haematopoetischer Stammzellen bieten prinzipiell eine unendliche Vielfalt klinischer Anwendungsmoeglichkeiten und Zukunftsperspektiven . Sie sind die Basis fuer Stammzelltransplantationen , d.h. fuer die Wiederherstellung der Haematopoese nach hochdosierter zytotoxischer Therapie und bilden die...	[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-um...	Praeparationen haematopoetischer Stammzellen bieten prinzipiell eine unendliche Vielfalt klinischer Anwendungsmoeglichkeiten und Zukunftsperspektiven . Sie sind die Basis fuer Stammzelltransplantationen , d.h. fuer die Wiederherstellung der Haematopoese nach hochdosierter zytotoxischer Therapie und bilden die Grundlage...	[ "Praeparationen", "haematopoetischer", "Stammzellen", "bieten", "prinzipiell", "eine", "unendliche", "Vielfalt", "klinischer", "Anwendungsmoeglichkeiten", "und", "Zukunftsperspektiven", ".", "Sie", "sind", "die", "Basis", "fuer", "Stammzelltransplantationen", ",", "d.h", "....	[ "umlsterm" ]
Ifenprodil is a CHEMICAL, Fluorescein is a CHEMICAL, GluN1 is a GENE-Y, GluN2B is a GENE-Y, N - Methyl - D - aspartate Receptor is a GENE-N	23532918_task0	Sentence: Synthesis and in Vitro Characterisation of Ifenprodil-Based Fluorescein Conjugates as GluN1/GluN2B N-Methyl-D-aspartate Receptor Antagonists. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: GENE-N, GENE-Y, CHEMICAL...	[ "O", "O", "O", "O", "O", "O", "B-CHEMICAL", "O", "O", "B-CHEMICAL", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "B-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "O", "O" ]	Synthesis and in Vitro Characterisation of Ifenprodil-Based Fluorescein Conjugates as GluN1/GluN2B N-Methyl-D-aspartate Receptor Antagonists.	[ "Synthesis", "and", "in", "Vitro", "Characterisation", "of", "Ifenprodil", "-", "Based", "Fluorescein", "Conjugates", "as", "GluN1", "/", "GluN2B", "N", "-", "Methyl", "-", "D", "-", "aspartate", "Receptor", "Antagonists", "." ]	[ "GENE-N", "CHEMICAL", "GENE-Y" ]
Ifenprodil is a CHEMICAL, Fluorescein is a CHEMICAL, GluN1 is a GENE-Y, GluN2B is a GENE-Y, N - Methyl - D - aspartate Receptor is a GENE-N	23532918_task1	Sentence: Synthesis and in Vitro Characterisation of Ifenprodil-Based Fluorescein Conjugates as GluN1/GluN2B N-Methyl-D-aspartate Receptor Antagonists. Instructions: please typing these entity words according to sentence: Ifenprodil, Fluorescein, GluN1, GluN2B, N - Methyl - D - aspartate Receptor ...	[ "O", "O", "O", "O", "O", "O", "B-CHEMICAL", "O", "O", "B-CHEMICAL", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "B-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "O", "O" ]	Synthesis and in Vitro Characterisation of Ifenprodil-Based Fluorescein Conjugates as GluN1/GluN2B N-Methyl-D-aspartate Receptor Antagonists.	[ "Synthesis", "and", "in", "Vitro", "Characterisation", "of", "Ifenprodil", "-", "Based", "Fluorescein", "Conjugates", "as", "GluN1", "/", "GluN2B", "N", "-", "Methyl", "-", "D", "-", "aspartate", "Receptor", "Antagonists", "." ]	[ "GENE-N", "CHEMICAL", "GENE-Y" ]
Ifenprodil, Fluorescein, GluN1, GluN2B, N - Methyl - D - aspartate Receptor	23532918_task2	Sentence: Synthesis and in Vitro Characterisation of Ifenprodil-Based Fluorescein Conjugates as GluN1/GluN2B N-Methyl-D-aspartate Receptor Antagonists. Instructions: please extract entity words from the input sentence	[ "O", "O", "O", "O", "O", "O", "B-CHEMICAL", "O", "O", "B-CHEMICAL", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "B-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "O", "O" ]	Synthesis and in Vitro Characterisation of Ifenprodil-Based Fluorescein Conjugates as GluN1/GluN2B N-Methyl-D-aspartate Receptor Antagonists.	[ "Synthesis", "and", "in", "Vitro", "Characterisation", "of", "Ifenprodil", "-", "Based", "Fluorescein", "Conjugates", "as", "GluN1", "/", "GluN2B", "N", "-", "Methyl", "-", "D", "-", "aspartate", "Receptor", "Antagonists", "." ]	[ "GENE-N", "CHEMICAL", "GENE-Y" ]
Fluvoxamine is a DRUG, tolbutamide is a DRUG, fluvoxamine is a DRUG, tolbutamide is a DRUG, fluvoxamine is a DRUG, tolbutamide is a DRUG, fluvoxamine is a DRUG, tolbutamide is a DRUG, tolbutamide is a DRUG, tolbutamide is a DRUG, 4-hydroxytolbutamide is a DRUG_N, carboxytolbutamide is a DRUG_N, fluvoxamine is a DRUG, t...	11180037_task0	Sentence: Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy parti...	[ "B-DRUG", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "B-DRUG", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O",...	Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy participants. I...	[ "Fluvoxamine", "inhibits", "the", "CYP2C9", "catalyzed", "biotransformation", "of", "tolbutamide", ".", "OBJECTIVE", ":", "Our", "objective", "was", "to", "examine", "the", "interaction", "between", "fluvoxamine", "and", "tolbutamide", "to", "confirm", "that", "fluv...	[ "DRUG_N", "DRUG" ]
Fluvoxamine is a DRUG, tolbutamide is a DRUG, fluvoxamine is a DRUG, tolbutamide is a DRUG, fluvoxamine is a DRUG, tolbutamide is a DRUG, fluvoxamine is a DRUG, tolbutamide is a DRUG, tolbutamide is a DRUG, tolbutamide is a DRUG, 4-hydroxytolbutamide is a DRUG_N, carboxytolbutamide is a DRUG_N, fluvoxamine is a DRUG, t...	11180037_task1	Sentence: Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy parti...	[ "B-DRUG", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "B-DRUG", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O",...	Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy participants. I...	[ "Fluvoxamine", "inhibits", "the", "CYP2C9", "catalyzed", "biotransformation", "of", "tolbutamide", ".", "OBJECTIVE", ":", "Our", "objective", "was", "to", "examine", "the", "interaction", "between", "fluvoxamine", "and", "tolbutamide", "to", "confirm", "that", "fluv...	[ "DRUG_N", "DRUG" ]
Fluvoxamine, tolbutamide, fluvoxamine, tolbutamide, fluvoxamine, tolbutamide, fluvoxamine, tolbutamide, tolbutamide, tolbutamide, 4-hydroxytolbutamide, carboxytolbutamide, fluvoxamine, tolbutamide, tolbutamide, 4-hydroxytolbutamide, carboxytolbutamide, tolbutamide, tolbutamide, fluvoxamine, Fluvoxamine	11180037_task2	Sentence: Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy parti...	[ "B-DRUG", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "B-DRUG", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O",...	Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy participants. I...	[ "Fluvoxamine", "inhibits", "the", "CYP2C9", "catalyzed", "biotransformation", "of", "tolbutamide", ".", "OBJECTIVE", ":", "Our", "objective", "was", "to", "examine", "the", "interaction", "between", "fluvoxamine", "and", "tolbutamide", "to", "confirm", "that", "fluv...	[ "DRUG_N", "DRUG" ]
GrpL is a Protein, SLP-76 is a Protein, SH2 domain - containing protein 76 is a Protein, SLP-76 is a Protein, Vav is a Protein, Grb2-related protein of the lymphoid system is a Protein, GrpL is a Protein, GrpL is a Protein, Grb2 is a Protein, GrpL is a Protein, SLP-76 is a Protein, Sos1 is a Protein, Sos2 is a Protein,...	152_task0	Sentence: GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor molecules. SH2 domain-containing protein 76 (SLP-76) interacts with the guanine nucleotide exchange...	[ "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Pr...	GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor molecules. SH2 domain-containing protein 76 (SLP-76) interacts with the guanine nucleotide exchange factor Va...	[ "GrpL", ",", "a", "Grb2-related", "adaptor", "protein", ",", "interacts", "with", "SLP-76", "to", "regulate", "nuclear", "factor", "of", "activated", "T", "cell", "activation", ".", "\n", "Propagation", "of", "signals", "from", "the", "T", "cell", "antigen", ...	[ "Protein", "Entity" ]
GrpL is a Protein, SLP-76 is a Protein, SH2 domain - containing protein 76 is a Protein, SLP-76 is a Protein, Vav is a Protein, Grb2-related protein of the lymphoid system is a Protein, GrpL is a Protein, GrpL is a Protein, Grb2 is a Protein, GrpL is a Protein, SLP-76 is a Protein, Sos1 is a Protein, Sos2 is a Protein,...	152_task1	Sentence: GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor molecules. SH2 domain-containing protein 76 (SLP-76) interacts with the guanine nucleotide exchange...	[ "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Pr...	GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor molecules. SH2 domain-containing protein 76 (SLP-76) interacts with the guanine nucleotide exchange factor Va...	[ "GrpL", ",", "a", "Grb2-related", "adaptor", "protein", ",", "interacts", "with", "SLP-76", "to", "regulate", "nuclear", "factor", "of", "activated", "T", "cell", "activation", ".", "\n", "Propagation", "of", "signals", "from", "the", "T", "cell", "antigen", ...	[ "Protein", "Entity" ]
GrpL, SLP-76, SH2 domain - containing protein 76, SLP-76, Vav, Grb2-related protein of the lymphoid system, GrpL, GrpL, Grb2, GrpL, SLP-76, Sos1, Sos2, Grb2, Sos1, Sos2, SLP-76, tyrosine, LAT, pp36/38, Grb2, GrpL, Grb2, GrpL, SLP-76, GrpL, SLP-76	152_task2	Sentence: GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor molecules. SH2 domain-containing protein 76 (SLP-76) interacts with the guanine nucleotide exchange...	[ "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Pr...	GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor molecules. SH2 domain-containing protein 76 (SLP-76) interacts with the guanine nucleotide exchange factor Va...	[ "GrpL", ",", "a", "Grb2-related", "adaptor", "protein", ",", "interacts", "with", "SLP-76", "to", "regulate", "nuclear", "factor", "of", "activated", "T", "cell", "activation", ".", "\n", "Propagation", "of", "signals", "from", "the", "T", "cell", "antigen", ...	[ "Protein", "Entity" ]
células tumorales malignas is a MORFOLOGIA_NEOPLASIA	647_task0	Sentence: Anamnesis Acude a Urgencias al 4º día del 1er ciclo, por cuadro de 24 horas de evolución consistente en palpitaciones y disnea progresiva hasta hacerse de reposo. Afebril en domicilio, sin dolor torácico, ni otra sintomatología acompañante. Ante hipotensión marcada, precisa la instauración de aminas en Urgenc...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	Anamnesis Acude a Urgencias al 4º día del 1er ciclo, por cuadro de 24 horas de evolución consistente en palpitaciones y disnea progresiva hasta hacerse de reposo. Afebril en domicilio, sin dolor torácico, ni otra sintomatología acompañante. Ante hipotensión marcada, precisa la instauración de aminas en Urgencias (norad...	[ "Anamnesis", "\n", "Acude", "a", "Urgencias", "al", "4º", "día", "del", "1er", "ciclo", ",", "por", "cuadro", "de", "24", "horas", "de", "evolución", "consistente", "en", "palpitaciones", "y", "disnea", "progresiva", "hasta", "hacerse", "de", "reposo", ".", ...	[ "MORFOLOGIA_NEOPLASIA" ]
células tumorales malignas is a MORFOLOGIA_NEOPLASIA	647_task1	Sentence: Anamnesis Acude a Urgencias al 4º día del 1er ciclo, por cuadro de 24 horas de evolución consistente en palpitaciones y disnea progresiva hasta hacerse de reposo. Afebril en domicilio, sin dolor torácico, ni otra sintomatología acompañante. Ante hipotensión marcada, precisa la instauración de aminas en Urgenc...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	Anamnesis Acude a Urgencias al 4º día del 1er ciclo, por cuadro de 24 horas de evolución consistente en palpitaciones y disnea progresiva hasta hacerse de reposo. Afebril en domicilio, sin dolor torácico, ni otra sintomatología acompañante. Ante hipotensión marcada, precisa la instauración de aminas en Urgencias (norad...	[ "Anamnesis", "\n", "Acude", "a", "Urgencias", "al", "4º", "día", "del", "1er", "ciclo", ",", "por", "cuadro", "de", "24", "horas", "de", "evolución", "consistente", "en", "palpitaciones", "y", "disnea", "progresiva", "hasta", "hacerse", "de", "reposo", ".", ...	[ "MORFOLOGIA_NEOPLASIA" ]
células tumorales malignas	647_task2	Sentence: Anamnesis Acude a Urgencias al 4º día del 1er ciclo, por cuadro de 24 horas de evolución consistente en palpitaciones y disnea progresiva hasta hacerse de reposo. Afebril en domicilio, sin dolor torácico, ni otra sintomatología acompañante. Ante hipotensión marcada, precisa la instauración de aminas en Urgenc...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...	Anamnesis Acude a Urgencias al 4º día del 1er ciclo, por cuadro de 24 horas de evolución consistente en palpitaciones y disnea progresiva hasta hacerse de reposo. Afebril en domicilio, sin dolor torácico, ni otra sintomatología acompañante. Ante hipotensión marcada, precisa la instauración de aminas en Urgencias (norad...	[ "Anamnesis", "\n", "Acude", "a", "Urgencias", "al", "4º", "día", "del", "1er", "ciclo", ",", "por", "cuadro", "de", "24", "horas", "de", "evolución", "consistente", "en", "palpitaciones", "y", "disnea", "progresiva", "hasta", "hacerse", "de", "reposo", ".", ...	[ "MORFOLOGIA_NEOPLASIA" ]
F is a Person, age is a Person, 18 to 70 is a Value, American Society of Anesthesiologists ( ASA ) is a Measurement, I e II is a Value, breast cancer is a Condition, DIN 2 e 3 , o LIN 2 e 3 sec . Tavassoli is a Scope, scheduled for is a Mood, nipple - sparing mastectomy is a Condition, simple mastectomy is a Condition,...	NCT02035904_inc_task0	Sentence: F; age 18 to 70 American Society of Anesthesiologists (ASA) I e II; breast cancer ( DIN 2 e 3, o LIN 2 e 3 sec. Tavassoli) scheduled for nipple-sparing mastectomy, simple mastectomy, skin-sparing mastectomy, skin-reducing mastectomy c, lymphnode biopsy and axillary dissection; immediate sub-pectoral prostheti...	[ "B-Person", "O", "B-Person", "B-Value", "I-Value", "I-Value", "O", "B-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "B-Value", "I-Value", "I-Value", "O", "O", "B-Condition", "I-Condition", "O", "B-Scope...	F; age 18 to 70 American Society of Anesthesiologists (ASA) I e II; breast cancer ( DIN 2 e 3, o LIN 2 e 3 sec. Tavassoli) scheduled for nipple-sparing mastectomy, simple mastectomy, skin-sparing mastectomy, skin-reducing mastectomy c, lymphnode biopsy and axillary dissection; immediate sub-pectoral prosthetic reconstr...	[ "F", ";", "age", "18", "to", "70", "\n", "American", "Society", "of", "Anesthesiologists", "(", "ASA", ")", "I", "e", "II", ";", "\n", "breast", "cancer", "(", "DIN", "2", "e", "3", ",", "o", "LIN", "2", "e", "3", "sec", ".", "Tavassoli", ")", ...	[ "Measurement", "Procedure", "Scope", "Condition", "Mood", "Value", "Qualifier", "Person" ]
F is a Person, age is a Person, 18 to 70 is a Value, American Society of Anesthesiologists ( ASA ) is a Measurement, I e II is a Value, breast cancer is a Condition, DIN 2 e 3 , o LIN 2 e 3 sec . Tavassoli is a Scope, scheduled for is a Mood, nipple - sparing mastectomy is a Condition, simple mastectomy is a Condition,...	NCT02035904_inc_task1	Sentence: F; age 18 to 70 American Society of Anesthesiologists (ASA) I e II; breast cancer ( DIN 2 e 3, o LIN 2 e 3 sec. Tavassoli) scheduled for nipple-sparing mastectomy, simple mastectomy, skin-sparing mastectomy, skin-reducing mastectomy c, lymphnode biopsy and axillary dissection; immediate sub-pectoral prostheti...	[ "B-Person", "O", "B-Person", "B-Value", "I-Value", "I-Value", "O", "B-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "B-Value", "I-Value", "I-Value", "O", "O", "B-Condition", "I-Condition", "O", "B-Scope...	F; age 18 to 70 American Society of Anesthesiologists (ASA) I e II; breast cancer ( DIN 2 e 3, o LIN 2 e 3 sec. Tavassoli) scheduled for nipple-sparing mastectomy, simple mastectomy, skin-sparing mastectomy, skin-reducing mastectomy c, lymphnode biopsy and axillary dissection; immediate sub-pectoral prosthetic reconstr...	[ "F", ";", "age", "18", "to", "70", "\n", "American", "Society", "of", "Anesthesiologists", "(", "ASA", ")", "I", "e", "II", ";", "\n", "breast", "cancer", "(", "DIN", "2", "e", "3", ",", "o", "LIN", "2", "e", "3", "sec", ".", "Tavassoli", ")", ...	[ "Measurement", "Procedure", "Scope", "Condition", "Mood", "Value", "Qualifier", "Person" ]
F, age, 18 to 70, American Society of Anesthesiologists ( ASA ), I e II, breast cancer, DIN 2 e 3 , o LIN 2 e 3 sec . Tavassoli, scheduled for, nipple - sparing mastectomy, simple mastectomy, skin - sparing mastectomy, skin - reducing mastectomy, lymphnode biopsy, axillary dissection, immediate, sub - pectoral prosthet...	NCT02035904_inc_task2	Sentence: F; age 18 to 70 American Society of Anesthesiologists (ASA) I e II; breast cancer ( DIN 2 e 3, o LIN 2 e 3 sec. Tavassoli) scheduled for nipple-sparing mastectomy, simple mastectomy, skin-sparing mastectomy, skin-reducing mastectomy c, lymphnode biopsy and axillary dissection; immediate sub-pectoral prostheti...	[ "B-Person", "O", "B-Person", "B-Value", "I-Value", "I-Value", "O", "B-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "B-Value", "I-Value", "I-Value", "O", "O", "B-Condition", "I-Condition", "O", "B-Scope...	F; age 18 to 70 American Society of Anesthesiologists (ASA) I e II; breast cancer ( DIN 2 e 3, o LIN 2 e 3 sec. Tavassoli) scheduled for nipple-sparing mastectomy, simple mastectomy, skin-sparing mastectomy, skin-reducing mastectomy c, lymphnode biopsy and axillary dissection; immediate sub-pectoral prosthetic reconstr...	[ "F", ";", "age", "18", "to", "70", "\n", "American", "Society", "of", "Anesthesiologists", "(", "ASA", ")", "I", "e", "II", ";", "\n", "breast", "cancer", "(", "DIN", "2", "e", "3", ",", "o", "LIN", "2", "e", "3", "sec", ".", "Tavassoli", ")", ...	[ "Measurement", "Procedure", "Scope", "Condition", "Mood", "Value", "Qualifier", "Person" ]
YE1998 is a Protein, 2000 is a Protein, Plu0634 is a Protein, Plu0635 is a Protein, P. luminescens is a Organism, plu1330 is a Protein, 1369 is a Protein, plu3217 is a Protein, plu3324 is a Protein, plu4117 is a Protein, plu3668 is a Protein, Y. enterocolitica is a Organism, YE1322 is a Protein, P. luminescens is a Org...	21_task0	Sentence: Repeats-in-toxin (RTX) and other toxins RTX proteins constitute another family of toxins that may contribute to the insecticidal activity of the two pathogens. A putative RTX-family toxin transporter is common to both pathogens (YE1998-2000, Plu0634/Plu0635). The P. luminescens genome comprises a gene cluste...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Prote...	Repeats-in-toxin (RTX) and other toxins RTX proteins constitute another family of toxins that may contribute to the insecticidal activity of the two pathogens. A putative RTX-family toxin transporter is common to both pathogens (YE1998-2000, Plu0634/Plu0635). The P. luminescens genome comprises a gene cluster encoding...	[ "Repeats", "-", "in", "-", "toxin", "(", "RTX", ")", "and", "other", "toxins", "\n", "RTX", "proteins", "constitute", "another", "family", "of", "toxins", "that", "may", "contribute", "to", "the", "insecticidal", "activity", "of", "the", "two", "pathogens", ...	[ "Organism", "Protein", "Chemical" ]
YE1998 is a Protein, 2000 is a Protein, Plu0634 is a Protein, Plu0635 is a Protein, P. luminescens is a Organism, plu1330 is a Protein, 1369 is a Protein, plu3217 is a Protein, plu3324 is a Protein, plu4117 is a Protein, plu3668 is a Protein, Y. enterocolitica is a Organism, YE1322 is a Protein, P. luminescens is a Org...	21_task1	Sentence: Repeats-in-toxin (RTX) and other toxins RTX proteins constitute another family of toxins that may contribute to the insecticidal activity of the two pathogens. A putative RTX-family toxin transporter is common to both pathogens (YE1998-2000, Plu0634/Plu0635). The P. luminescens genome comprises a gene cluste...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Prote...	Repeats-in-toxin (RTX) and other toxins RTX proteins constitute another family of toxins that may contribute to the insecticidal activity of the two pathogens. A putative RTX-family toxin transporter is common to both pathogens (YE1998-2000, Plu0634/Plu0635). The P. luminescens genome comprises a gene cluster encoding...	[ "Repeats", "-", "in", "-", "toxin", "(", "RTX", ")", "and", "other", "toxins", "\n", "RTX", "proteins", "constitute", "another", "family", "of", "toxins", "that", "may", "contribute", "to", "the", "insecticidal", "activity", "of", "the", "two", "pathogens", ...	[ "Organism", "Protein", "Chemical" ]
YE1998, 2000, Plu0634, Plu0635, P. luminescens, plu1330, 1369, plu3217, plu3324, plu4117, plu3668, Y. enterocolitica, YE1322, P. luminescens, Plu3209, X. nematophila, Plu2288, Plu0359, YE2685, Y. enterocolitica, YE2091, P. luminescens ssp . akhurstii strain W14, P. luminescens ssp . laumondii strain TT01, P. luminescen...	21_task2	Sentence: Repeats-in-toxin (RTX) and other toxins RTX proteins constitute another family of toxins that may contribute to the insecticidal activity of the two pathogens. A putative RTX-family toxin transporter is common to both pathogens (YE1998-2000, Plu0634/Plu0635). The P. luminescens genome comprises a gene cluste...	[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Prote...	Repeats-in-toxin (RTX) and other toxins RTX proteins constitute another family of toxins that may contribute to the insecticidal activity of the two pathogens. A putative RTX-family toxin transporter is common to both pathogens (YE1998-2000, Plu0634/Plu0635). The P. luminescens genome comprises a gene cluster encoding...	[ "Repeats", "-", "in", "-", "toxin", "(", "RTX", ")", "and", "other", "toxins", "\n", "RTX", "proteins", "constitute", "another", "family", "of", "toxins", "that", "may", "contribute", "to", "the", "insecticidal", "activity", "of", "the", "two", "pathogens", ...	[ "Organism", "Protein", "Chemical" ]
Monitoring is an umlsterm, pressure is an umlsterm	DerRadiologe.80380624.eng.abstr_task0	Sentence: Purpose : Monitoring of intraluminal pressure in standardized enteroclysis . Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: umlsterm	[ "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O" ]	Purpose : Monitoring of intraluminal pressure in standardized enteroclysis .	[ "Purpose", ":", "Monitoring", "of", "intraluminal", "pressure", "in", "standardized", "enteroclysis", "." ]	[ "umlsterm" ]

Pionierzeit is an umlsterm, Replantation is an umlsterm, Extremitaet is an umlsterm, Schmerzen is an umlsterm, Replantation is an umlsterm, Unfallmechanismus is an umlsterm, Replantation is an umlsterm, Patienten is an umlsterm

DerUnfallchirurg.71000694.ger.abstr_task0

Sentence: In der Pionierzeit der Replantationschirurgie wurde der Erfolg alleine an der Vitalitaet des Replantates ( Ueberlebensrate ) gemessen . Spricht man heute von einer erfolgreichen Replantation muessen neben der Vitalitaet zusaetzliche Kriterien wie , ein geringes Replantationsrisiko , eine funktionelle Extremit...

[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O...

In der Pionierzeit der Replantationschirurgie wurde der Erfolg alleine an der Vitalitaet des Replantates ( Ueberlebensrate ) gemessen . Spricht man heute von einer erfolgreichen Replantation muessen neben der Vitalitaet zusaetzliche Kriterien wie , ein geringes Replantationsrisiko , eine funktionelle Extremitaet " " na...

[ "In", "der", "Pionierzeit", "der", "Replantationschirurgie", "wurde", "der", "Erfolg", "alleine", "an", "der", "Vitalitaet", "des", "Replantates", "(", "Ueberlebensrate", ")", "gemessen", ".", "Spricht", "man", "heute", "von", "einer", "erfolgreichen", "Replantation...

[ "umlsterm" ]

Pionierzeit is an umlsterm, Replantation is an umlsterm, Extremitaet is an umlsterm, Schmerzen is an umlsterm, Replantation is an umlsterm, Unfallmechanismus is an umlsterm, Replantation is an umlsterm, Patienten is an umlsterm

DerUnfallchirurg.71000694.ger.abstr_task1

Sentence: In der Pionierzeit der Replantationschirurgie wurde der Erfolg alleine an der Vitalitaet des Replantates ( Ueberlebensrate ) gemessen . Spricht man heute von einer erfolgreichen Replantation muessen neben der Vitalitaet zusaetzliche Kriterien wie , ein geringes Replantationsrisiko , eine funktionelle Extremit...

[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O...

In der Pionierzeit der Replantationschirurgie wurde der Erfolg alleine an der Vitalitaet des Replantates ( Ueberlebensrate ) gemessen . Spricht man heute von einer erfolgreichen Replantation muessen neben der Vitalitaet zusaetzliche Kriterien wie , ein geringes Replantationsrisiko , eine funktionelle Extremitaet " " na...

[ "In", "der", "Pionierzeit", "der", "Replantationschirurgie", "wurde", "der", "Erfolg", "alleine", "an", "der", "Vitalitaet", "des", "Replantates", "(", "Ueberlebensrate", ")", "gemessen", ".", "Spricht", "man", "heute", "von", "einer", "erfolgreichen", "Replantation...

[ "umlsterm" ]

Pionierzeit, Replantation, Extremitaet, Schmerzen, Replantation, Unfallmechanismus, Replantation, Patienten

DerUnfallchirurg.71000694.ger.abstr_task2

Sentence: In der Pionierzeit der Replantationschirurgie wurde der Erfolg alleine an der Vitalitaet des Replantates ( Ueberlebensrate ) gemessen . Spricht man heute von einer erfolgreichen Replantation muessen neben der Vitalitaet zusaetzliche Kriterien wie , ein geringes Replantationsrisiko , eine funktionelle Extremit...

[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O...

In der Pionierzeit der Replantationschirurgie wurde der Erfolg alleine an der Vitalitaet des Replantates ( Ueberlebensrate ) gemessen . Spricht man heute von einer erfolgreichen Replantation muessen neben der Vitalitaet zusaetzliche Kriterien wie , ein geringes Replantationsrisiko , eine funktionelle Extremitaet " " na...

[ "In", "der", "Pionierzeit", "der", "Replantationschirurgie", "wurde", "der", "Erfolg", "alleine", "an", "der", "Vitalitaet", "des", "Replantates", "(", "Ueberlebensrate", ")", "gemessen", ".", "Spricht", "man", "heute", "von", "einer", "erfolgreichen", "Replantation...

[ "umlsterm" ]

transfer is an umlsterm, safety is an umlsterm, interaction is an umlsterm, teleradiology is an umlsterm, selection is an umlsterm

DerRadiologe.70370336.eng.abstr_task0

Sentence: Teleradiologysystems can differ considerably in their features . The most important differences lie in the mode of image data acquisition , data transfer , data safety aspects and the possibilities of interaction between seperate teleradiology units . A selection of commercially available teleradiologysystems...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", ...

Teleradiologysystems can differ considerably in their features . The most important differences lie in the mode of image data acquisition , data transfer , data safety aspects and the possibilities of interaction between seperate teleradiology units . A selection of commercially available teleradiologysystems is presen...

[ "Teleradiologysystems", "can", "differ", "considerably", "in", "their", "features", ".", "The", "most", "important", "differences", "lie", "in", "the", "mode", "of", "image", "data", "acquisition", ",", "data", "transfer", ",", "data", "safety", "aspects", "and"...

[ "umlsterm" ]

transfer is an umlsterm, safety is an umlsterm, interaction is an umlsterm, teleradiology is an umlsterm, selection is an umlsterm

DerRadiologe.70370336.eng.abstr_task1

Sentence: Teleradiologysystems can differ considerably in their features . The most important differences lie in the mode of image data acquisition , data transfer , data safety aspects and the possibilities of interaction between seperate teleradiology units . A selection of commercially available teleradiologysystems...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", ...

Teleradiologysystems can differ considerably in their features . The most important differences lie in the mode of image data acquisition , data transfer , data safety aspects and the possibilities of interaction between seperate teleradiology units . A selection of commercially available teleradiologysystems is presen...

[ "Teleradiologysystems", "can", "differ", "considerably", "in", "their", "features", ".", "The", "most", "important", "differences", "lie", "in", "the", "mode", "of", "image", "data", "acquisition", ",", "data", "transfer", ",", "data", "safety", "aspects", "and"...

[ "umlsterm" ]

transfer, safety, interaction, teleradiology, selection

DerRadiologe.70370336.eng.abstr_task2

Sentence: Teleradiologysystems can differ considerably in their features . The most important differences lie in the mode of image data acquisition , data transfer , data safety aspects and the possibilities of interaction between seperate teleradiology units . A selection of commercially available teleradiologysystems...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", ...

Teleradiologysystems can differ considerably in their features . The most important differences lie in the mode of image data acquisition , data transfer , data safety aspects and the possibilities of interaction between seperate teleradiology units . A selection of commercially available teleradiologysystems is presen...

[ "Teleradiologysystems", "can", "differ", "considerably", "in", "their", "features", ".", "The", "most", "important", "differences", "lie", "in", "the", "mode", "of", "image", "data", "acquisition", ",", "data", "transfer", ",", "data", "safety", "aspects", "and"...

[ "umlsterm" ]

Drucksenkung is an umlsterm, Glaukomaugen is an umlsterm

DerOpthalmologe.70940665.ger.abstr_task0

Sentence: Problemstellung : Wie weit ist eine Drucksenkung bei Glaukomaugen durch punktfoermige Ablation des Trabekelwerks mit dem Excimerlaser moeglich ? Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: umlsterm

[ "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

Problemstellung : Wie weit ist eine Drucksenkung bei Glaukomaugen durch punktfoermige Ablation des Trabekelwerks mit dem Excimerlaser moeglich ?

[ "Problemstellung", ":", "Wie", "weit", "ist", "eine", "Drucksenkung", "bei", "Glaukomaugen", "durch", "punktfoermige", "Ablation", "des", "Trabekelwerks", "mit", "dem", "Excimerlaser", "moeglich", "?" ]

[ "umlsterm" ]

Drucksenkung is an umlsterm, Glaukomaugen is an umlsterm

DerOpthalmologe.70940665.ger.abstr_task1

Sentence: Problemstellung : Wie weit ist eine Drucksenkung bei Glaukomaugen durch punktfoermige Ablation des Trabekelwerks mit dem Excimerlaser moeglich ? Instructions: please typing these entity words according to sentence: Drucksenkung, Glaukomaugen Options: umlsterm

[ "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

Problemstellung : Wie weit ist eine Drucksenkung bei Glaukomaugen durch punktfoermige Ablation des Trabekelwerks mit dem Excimerlaser moeglich ?

[ "Problemstellung", ":", "Wie", "weit", "ist", "eine", "Drucksenkung", "bei", "Glaukomaugen", "durch", "punktfoermige", "Ablation", "des", "Trabekelwerks", "mit", "dem", "Excimerlaser", "moeglich", "?" ]

[ "umlsterm" ]

Drucksenkung, Glaukomaugen

DerOpthalmologe.70940665.ger.abstr_task2

Sentence: Problemstellung : Wie weit ist eine Drucksenkung bei Glaukomaugen durch punktfoermige Ablation des Trabekelwerks mit dem Excimerlaser moeglich ? Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

Problemstellung : Wie weit ist eine Drucksenkung bei Glaukomaugen durch punktfoermige Ablation des Trabekelwerks mit dem Excimerlaser moeglich ?

[ "Problemstellung", ":", "Wie", "weit", "ist", "eine", "Drucksenkung", "bei", "Glaukomaugen", "durch", "punktfoermige", "Ablation", "des", "Trabekelwerks", "mit", "dem", "Excimerlaser", "moeglich", "?" ]

[ "umlsterm" ]

man is an umlsterm, giant - cell is an umlsterm, tumor is an umlsterm, right is an umlsterm, temporomandibular joint is an umlsterm, growth is an umlsterm, treatment is an umlsterm, endotracheal anesthesia is an umlsterm, recurrence is an umlsterm, Differential diagnosis is an umlsterm, therapy is an umlsterm

MundKieferGesichtschirurgie.80020279.eng.abstr_task0

Sentence: A 63-year-old man is presented in whom a tenosynovial giant-cell tumor destroyed the right temporomandibular joint and fossa and showed extensive intracranial growth . Because of uncharacteristic complaints , a symptomatic treatment was performed elsewhere . The lesion was finally resected under endotracheal ...

[ "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "B-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O",...

A 63-year-old man is presented in whom a tenosynovial giant-cell tumor destroyed the right temporomandibular joint and fossa and showed extensive intracranial growth . Because of uncharacteristic complaints , a symptomatic treatment was performed elsewhere . The lesion was finally resected under endotracheal anesthesia...

[ "A", "63-year", "-", "old", "man", "is", "presented", "in", "whom", "a", "tenosynovial", "giant", "-", "cell", "tumor", "destroyed", "the", "right", "temporomandibular", "joint", "and", "fossa", "and", "showed", "extensive", "intracranial", "growth", ".", "Bec...

[ "umlsterm" ]

man is an umlsterm, giant - cell is an umlsterm, tumor is an umlsterm, right is an umlsterm, temporomandibular joint is an umlsterm, growth is an umlsterm, treatment is an umlsterm, endotracheal anesthesia is an umlsterm, recurrence is an umlsterm, Differential diagnosis is an umlsterm, therapy is an umlsterm

MundKieferGesichtschirurgie.80020279.eng.abstr_task1

Sentence: A 63-year-old man is presented in whom a tenosynovial giant-cell tumor destroyed the right temporomandibular joint and fossa and showed extensive intracranial growth . Because of uncharacteristic complaints , a symptomatic treatment was performed elsewhere . The lesion was finally resected under endotracheal ...

[ "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "B-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O",...

A 63-year-old man is presented in whom a tenosynovial giant-cell tumor destroyed the right temporomandibular joint and fossa and showed extensive intracranial growth . Because of uncharacteristic complaints , a symptomatic treatment was performed elsewhere . The lesion was finally resected under endotracheal anesthesia...

[ "A", "63-year", "-", "old", "man", "is", "presented", "in", "whom", "a", "tenosynovial", "giant", "-", "cell", "tumor", "destroyed", "the", "right", "temporomandibular", "joint", "and", "fossa", "and", "showed", "extensive", "intracranial", "growth", ".", "Bec...

[ "umlsterm" ]

man, giant - cell, tumor, right, temporomandibular joint, growth, treatment, endotracheal anesthesia, recurrence, Differential diagnosis, therapy

MundKieferGesichtschirurgie.80020279.eng.abstr_task2

Sentence: A 63-year-old man is presented in whom a tenosynovial giant-cell tumor destroyed the right temporomandibular joint and fossa and showed extensive intracranial growth . Because of uncharacteristic complaints , a symptomatic treatment was performed elsewhere . The lesion was finally resected under endotracheal ...

[ "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "I-umlsterm", "I-umlsterm", "B-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "I-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O",...

A 63-year-old man is presented in whom a tenosynovial giant-cell tumor destroyed the right temporomandibular joint and fossa and showed extensive intracranial growth . Because of uncharacteristic complaints , a symptomatic treatment was performed elsewhere . The lesion was finally resected under endotracheal anesthesia...

[ "A", "63-year", "-", "old", "man", "is", "presented", "in", "whom", "a", "tenosynovial", "giant", "-", "cell", "tumor", "destroyed", "the", "right", "temporomandibular", "joint", "and", "fossa", "and", "showed", "extensive", "intracranial", "growth", ".", "Bec...

[ "umlsterm" ]

Metoclopramide is a DRUG, MONUROL is a BRAND, metoclopramide is a DRUG, fosfomycin is a DRUG, Cimetidine is a DRUG, Cimetidine is a DRUG, fosfomycin is a DRUG, MONUROL is a BRAND

Fosfomycin_ddi_task0

Sentence: Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Cimetidine: Cimetidine does not affect the ph...

[ "B-DRUG", "O", "O", "O", "O", "B-BRAND", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "B-DRUG", "O", ...

Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Cimetidine: Cimetidine does not affect the pharmacokine...

[ "Metoclopramide", ":", "When", "coadministered", "with", "MONUROL", ",", "metoclopramide", ",", "a", "drug", "which", "increases", "gastrointestinal", "motility", ",", "lowers", "the", "serum", "concentration", "and", "urinary", "excretion", "of", "fosfomycin", ".",...

[ "DRUG", "BRAND" ]

Metoclopramide is a DRUG, MONUROL is a BRAND, metoclopramide is a DRUG, fosfomycin is a DRUG, Cimetidine is a DRUG, Cimetidine is a DRUG, fosfomycin is a DRUG, MONUROL is a BRAND

Fosfomycin_ddi_task1

Sentence: Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Cimetidine: Cimetidine does not affect the ph...

[ "B-DRUG", "O", "O", "O", "O", "B-BRAND", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "B-DRUG", "O", ...

Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Cimetidine: Cimetidine does not affect the pharmacokine...

[ "Metoclopramide", ":", "When", "coadministered", "with", "MONUROL", ",", "metoclopramide", ",", "a", "drug", "which", "increases", "gastrointestinal", "motility", ",", "lowers", "the", "serum", "concentration", "and", "urinary", "excretion", "of", "fosfomycin", ".",...

[ "DRUG", "BRAND" ]

Metoclopramide, MONUROL, metoclopramide, fosfomycin, Cimetidine, Cimetidine, fosfomycin, MONUROL

Fosfomycin_ddi_task2

Sentence: Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Cimetidine: Cimetidine does not affect the ph...

[ "B-DRUG", "O", "O", "O", "O", "B-BRAND", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "B-DRUG", "O", ...

Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Cimetidine: Cimetidine does not affect the pharmacokine...

[ "Metoclopramide", ":", "When", "coadministered", "with", "MONUROL", ",", "metoclopramide", ",", "a", "drug", "which", "increases", "gastrointestinal", "motility", ",", "lowers", "the", "serum", "concentration", "and", "urinary", "excretion", "of", "fosfomycin", ".",...

[ "DRUG", "BRAND" ]

I - DOX is a chemical, TTR is a protein, FAP is a disease

1.0alpha7.train.194_task0

Sentence: The data presented in this study clearly show that I-DOX binds specifically to TTR amyloid fibrils in tissues from patients with FAP. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: disease, chemical, protein ...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-chemical", "I-chemical", "I-chemical", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "B-disease", "O" ]

The data presented in this study clearly show that I-DOX binds specifically to TTR amyloid fibrils in tissues from patients with FAP.

[ "The", "data", "presented", "in", "this", "study", "clearly", "show", "that", "I", "-", "DOX", "binds", "specifically", "to", "TTR", "amyloid", "fibrils", "in", "tissues", "from", "patients", "with", "FAP", "." ]

[ "chemical", "protein", "disease" ]

I - DOX is a chemical, TTR is a protein, FAP is a disease

1.0alpha7.train.194_task1

Sentence: The data presented in this study clearly show that I-DOX binds specifically to TTR amyloid fibrils in tissues from patients with FAP. Instructions: please typing these entity words according to sentence: I - DOX, TTR, FAP Options: disease, chemical, protein

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-chemical", "I-chemical", "I-chemical", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "B-disease", "O" ]

The data presented in this study clearly show that I-DOX binds specifically to TTR amyloid fibrils in tissues from patients with FAP.

[ "The", "data", "presented", "in", "this", "study", "clearly", "show", "that", "I", "-", "DOX", "binds", "specifically", "to", "TTR", "amyloid", "fibrils", "in", "tissues", "from", "patients", "with", "FAP", "." ]

[ "chemical", "protein", "disease" ]

I - DOX, TTR, FAP

1.0alpha7.train.194_task2

Sentence: The data presented in this study clearly show that I-DOX binds specifically to TTR amyloid fibrils in tissues from patients with FAP. Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-chemical", "I-chemical", "I-chemical", "O", "O", "O", "B-protein", "O", "O", "O", "O", "O", "O", "O", "B-disease", "O" ]

The data presented in this study clearly show that I-DOX binds specifically to TTR amyloid fibrils in tissues from patients with FAP.

[ "The", "data", "presented", "in", "this", "study", "clearly", "show", "that", "I", "-", "DOX", "binds", "specifically", "to", "TTR", "amyloid", "fibrils", "in", "tissues", "from", "patients", "with", "FAP", "." ]

[ "chemical", "protein", "disease" ]

prostaglandin is a CHEMICAL

12713596_task0

Sentence: Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: CHEMICAL

[ "O", "B-CHEMICAL", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair.

[ "Cyclooxygenase-1-coupled", "prostaglandin", "biosynthesis", "constitutes", "an", "essential", "prerequisite", "for", "skin", "repair", "." ]

[ "GENE-N", "CHEMICAL", "GENE-Y" ]

prostaglandin is a CHEMICAL

12713596_task1

Sentence: Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. Instructions: please typing these entity words according to sentence: prostaglandin Options: CHEMICAL

[ "O", "B-CHEMICAL", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair.

[ "Cyclooxygenase-1-coupled", "prostaglandin", "biosynthesis", "constitutes", "an", "essential", "prerequisite", "for", "skin", "repair", "." ]

[ "GENE-N", "CHEMICAL", "GENE-Y" ]

prostaglandin

12713596_task2

Sentence: Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. Instructions: please extract entity words from the input sentence

[ "O", "B-CHEMICAL", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair.

[ "Cyclooxygenase-1-coupled", "prostaglandin", "biosynthesis", "constitutes", "an", "essential", "prerequisite", "for", "skin", "repair", "." ]

[ "GENE-N", "CHEMICAL", "GENE-Y" ]

I kappaB alpha is a Protein, serines 32 and 36 is a Entity, I kappaB alpha is a Protein, p50 is a Protein, relA is a Protein, I kappaB alpha is a Protein, I kappaB alpha is a Protein, Tax is a Protein, I kappaB beta is a Protein, I kappaB epsilon is a Protein, I kappaB alpha is a Protein, I kappaB beta is a Protein, I ...

9032271_task0

Sentence: Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). Associated with its inhibitor, I kappaB, NF-kappaB re...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). Associated with its inhibitor, I kappaB, NF-kappaB resides as a...

[ "Characterization", "of", "a", "mutant", "cell", "line", "that", "does", "not", "activate", "NF", "-", "kappaB", "in", "response", "to", "multiple", "stimuli", ".", "\n", "Numerous", "genes", "required", "during", "the", "immune", "or", "inflammation", "respon...

[ "Entity", "Protein" ]

I kappaB alpha is a Protein, serines 32 and 36 is a Entity, I kappaB alpha is a Protein, p50 is a Protein, relA is a Protein, I kappaB alpha is a Protein, I kappaB alpha is a Protein, Tax is a Protein, I kappaB beta is a Protein, I kappaB epsilon is a Protein, I kappaB alpha is a Protein, I kappaB beta is a Protein, I ...

9032271_task1

Sentence: Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). Associated with its inhibitor, I kappaB, NF-kappaB re...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). Associated with its inhibitor, I kappaB, NF-kappaB resides as a...

[ "Characterization", "of", "a", "mutant", "cell", "line", "that", "does", "not", "activate", "NF", "-", "kappaB", "in", "response", "to", "multiple", "stimuli", ".", "\n", "Numerous", "genes", "required", "during", "the", "immune", "or", "inflammation", "respon...

[ "Entity", "Protein" ]

I kappaB alpha, serines 32 and 36, I kappaB alpha, p50, relA, I kappaB alpha, I kappaB alpha, Tax, I kappaB beta, I kappaB epsilon, I kappaB alpha, I kappaB beta, I kappaB epsilon

9032271_task2

Sentence: Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). Associated with its inhibitor, I kappaB, NF-kappaB re...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Numerous genes required during the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB). Associated with its inhibitor, I kappaB, NF-kappaB resides as a...

[ "Characterization", "of", "a", "mutant", "cell", "line", "that", "does", "not", "activate", "NF", "-", "kappaB", "in", "response", "to", "multiple", "stimuli", ".", "\n", "Numerous", "genes", "required", "during", "the", "immune", "or", "inflammation", "respon...

[ "Entity", "Protein" ]

Toxicities , including thromboembolism is an outcome, overall survival is an outcome

892_task0

Sentence: Toxicities , including thromboembolism , and overall survival were similar . Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: outcome

[ "B-outcome", "I-outcome", "I-outcome", "I-outcome", "O", "O", "B-outcome", "I-outcome", "O", "O", "O" ]

Toxicities , including thromboembolism , and overall survival were similar .

[ "Toxicities", ",", "including", "thromboembolism", ",", "and", "overall", "survival", "were", "similar", "." ]

[ "outcome" ]

Toxicities , including thromboembolism is an outcome, overall survival is an outcome

892_task1

Sentence: Toxicities , including thromboembolism , and overall survival were similar . Instructions: please typing these entity words according to sentence: Toxicities , including thromboembolism, overall survival Options: outcome

[ "B-outcome", "I-outcome", "I-outcome", "I-outcome", "O", "O", "B-outcome", "I-outcome", "O", "O", "O" ]

Toxicities , including thromboembolism , and overall survival were similar .

[ "Toxicities", ",", "including", "thromboembolism", ",", "and", "overall", "survival", "were", "similar", "." ]

[ "outcome" ]

Toxicities , including thromboembolism, overall survival

892_task2

Sentence: Toxicities , including thromboembolism , and overall survival were similar . Instructions: please extract entity words from the input sentence

[ "B-outcome", "I-outcome", "I-outcome", "I-outcome", "O", "O", "B-outcome", "I-outcome", "O", "O", "O" ]

Toxicities , including thromboembolism , and overall survival were similar .

[ "Toxicities", ",", "including", "thromboembolism", ",", "and", "overall", "survival", "were", "similar", "." ]

[ "outcome" ]

hypertension is a Participant_Condition, reduced sodium intake is a Intervention_Physical, Dietary Approaches to Stop Hypertension ( DASH ) diet is a Intervention_Other, blood pressure ( BP ) is a Outcome_Physical, Adults is a Participant_Age, systolic BP 120 - 159 mm Hg and diastolic BP 80 - 95 mm Hg is a Participant_...

17841_task0

Sentence: Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control . The authors hypothesized that the Dietary Approaches to Stop Hypertension ( DASH ) diet and reduced sodium intake would control stage 1 hypertension and reduce high-normal blood pressure ( BP ) to ...

[ "O", "O", "O", "O", "O", "O", "O", "B-Participant_Condition", "O", "O", "B-Intervention_Physical", "I-Intervention_Physical", "I-Intervention_Physical", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Intervention_Other", "I-Intervention_Other", "I-Intervention...

Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control . The authors hypothesized that the Dietary Approaches to Stop Hypertension ( DASH ) diet and reduced sodium intake would control stage 1 hypertension and reduce high-normal blood pressure ( BP ) to optimal le...

[ "Effect", "of", "the", "dietary", "approaches", "to", "stop", "hypertension", "diet", "and", "reduced", "sodium", "intake", "on", "blood", "pressure", "control", ".", "The", "authors", "hypothesized", "that", "the", "Dietary", "Approaches", "to", "Stop", "Hypert...

[ "Participant_Condition", "Intervention_Other", "Intervention_Control", "Outcome_Physical", "Intervention_Educational", "Intervention_Physical", "Participant_Age" ]

hypertension is a Participant_Condition, reduced sodium intake is a Intervention_Physical, Dietary Approaches to Stop Hypertension ( DASH ) diet is a Intervention_Other, blood pressure ( BP ) is a Outcome_Physical, Adults is a Participant_Age, systolic BP 120 - 159 mm Hg and diastolic BP 80 - 95 mm Hg is a Participant_...

17841_task1

Sentence: Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control . The authors hypothesized that the Dietary Approaches to Stop Hypertension ( DASH ) diet and reduced sodium intake would control stage 1 hypertension and reduce high-normal blood pressure ( BP ) to ...

[ "O", "O", "O", "O", "O", "O", "O", "B-Participant_Condition", "O", "O", "B-Intervention_Physical", "I-Intervention_Physical", "I-Intervention_Physical", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Intervention_Other", "I-Intervention_Other", "I-Intervention...

Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control . The authors hypothesized that the Dietary Approaches to Stop Hypertension ( DASH ) diet and reduced sodium intake would control stage 1 hypertension and reduce high-normal blood pressure ( BP ) to optimal le...

[ "Effect", "of", "the", "dietary", "approaches", "to", "stop", "hypertension", "diet", "and", "reduced", "sodium", "intake", "on", "blood", "pressure", "control", ".", "The", "authors", "hypothesized", "that", "the", "Dietary", "Approaches", "to", "Stop", "Hypert...

[ "Participant_Condition", "Intervention_Other", "Intervention_Control", "Outcome_Physical", "Intervention_Educational", "Intervention_Physical", "Participant_Age" ]

hypertension, reduced sodium intake, Dietary Approaches to Stop Hypertension ( DASH ) diet, blood pressure ( BP ), Adults, systolic BP 120 - 159 mm Hg and diastolic BP 80 - 95 mm Hg, DASH diet, typical American ( control ) diet, BP control, increased BP control, maximum BP control rate, DASH / lower sodium diet, contro...

17841_task2

Sentence: Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control . The authors hypothesized that the Dietary Approaches to Stop Hypertension ( DASH ) diet and reduced sodium intake would control stage 1 hypertension and reduce high-normal blood pressure ( BP ) to ...

[ "O", "O", "O", "O", "O", "O", "O", "B-Participant_Condition", "O", "O", "B-Intervention_Physical", "I-Intervention_Physical", "I-Intervention_Physical", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Intervention_Other", "I-Intervention_Other", "I-Intervention...

Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control . The authors hypothesized that the Dietary Approaches to Stop Hypertension ( DASH ) diet and reduced sodium intake would control stage 1 hypertension and reduce high-normal blood pressure ( BP ) to optimal le...

[ "Effect", "of", "the", "dietary", "approaches", "to", "stop", "hypertension", "diet", "and", "reduced", "sodium", "intake", "on", "blood", "pressure", "control", ".", "The", "authors", "hypothesized", "that", "the", "Dietary", "Approaches", "to", "Stop", "Hypert...

[ "Participant_Condition", "Intervention_Other", "Intervention_Control", "Outcome_Physical", "Intervention_Educational", "Intervention_Physical", "Participant_Age" ]

CHH is a Gene, CHH is a Gene, CHH is a Gene, CHH is a Gene, CHH is a Gene

225_task0

Sentence: High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both f...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Gene", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...

High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both family seri...

[ "High", "-", "resolution", "linkage", "-", "disequilibrium", "mapping", "of", "the", "cartilage", "-", "hair", "hypoplasia", "gene", ".", "We", "recently", "assigned", "the", "gene", "for", "an", "autosomal", "recessive", "skeletal", "dysplasia", ",", "cartilage...

[ "Gene" ]

CHH is a Gene, CHH is a Gene, CHH is a Gene, CHH is a Gene, CHH is a Gene

225_task1

Sentence: High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both f...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Gene", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...

High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both family seri...

[ "High", "-", "resolution", "linkage", "-", "disequilibrium", "mapping", "of", "the", "cartilage", "-", "hair", "hypoplasia", "gene", ".", "We", "recently", "assigned", "the", "gene", "for", "an", "autosomal", "recessive", "skeletal", "dysplasia", ",", "cartilage...

[ "Gene" ]

CHH, CHH, CHH, CHH, CHH

225_task2

Sentence: High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both f...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Gene", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...

High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. We recently assigned the gene for an autosomal recessive skeletal dysplasia, cartilage-hair hypoplasia (CHH), to 9p21-p13 in Finnish and Amish families. An association was observed between CHH and alleles at D9S163 in both family seri...

[ "High", "-", "resolution", "linkage", "-", "disequilibrium", "mapping", "of", "the", "cartilage", "-", "hair", "hypoplasia", "gene", ".", "We", "recently", "assigned", "the", "gene", "for", "an", "autosomal", "recessive", "skeletal", "dysplasia", ",", "cartilage...

[ "Gene" ]

urologic surgery is a Procedure

NCT02805504_inc_task0

Sentence: Patients undergoing urologic surgery. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: Procedure

[ "O", "O", "B-Procedure", "I-Procedure", "O", "O" ]

Patients undergoing urologic surgery.

[ "Patients", "undergoing", "urologic", "surgery", ".", "\n" ]

[ "Procedure" ]

urologic surgery is a Procedure

NCT02805504_inc_task1

Sentence: Patients undergoing urologic surgery. Instructions: please typing these entity words according to sentence: urologic surgery Options: Procedure

[ "O", "O", "B-Procedure", "I-Procedure", "O", "O" ]

Patients undergoing urologic surgery.

[ "Patients", "undergoing", "urologic", "surgery", ".", "\n" ]

[ "Procedure" ]

urologic surgery

NCT02805504_inc_task2

Sentence: Patients undergoing urologic surgery. Instructions: please extract entity words from the input sentence

[ "O", "O", "B-Procedure", "I-Procedure", "O", "O" ]

Patients undergoing urologic surgery.

[ "Patients", "undergoing", "urologic", "surgery", ".", "\n" ]

[ "Procedure" ]

Embryonenschutzgesetz is an umlsterm, Forschung is an umlsterm, Embryonen is an umlsterm, Deutschland is an umlsterm, Zellen is an umlsterm, Embryo is an umlsterm, Stammzellen is an umlsterm, Embryos is an umlsterm, Embryonenschutzgesetz is an umlsterm, selbst is an umlsterm, Embryo is an umlsterm, Zellen is an umlster...

Reproduktionsmedizin.90150159.ger.abstr_task0

Sentence: Das Embryonenschutzgesetz verbietet jegliche fremdnuetzige Forschung an und mit Embryonen . Damit ist in Deutschland die Entnahme von pluripotenten Zellen aus einem Embryo verboten . Die Gewinnung von embryonalen Stammzellen ( ES-Zellen ) aus Blastozysten erfolgt zu anderen Zwecken als zur Erhaltung des Embry...

[ "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "...

Das Embryonenschutzgesetz verbietet jegliche fremdnuetzige Forschung an und mit Embryonen . Damit ist in Deutschland die Entnahme von pluripotenten Zellen aus einem Embryo verboten . Die Gewinnung von embryonalen Stammzellen ( ES-Zellen ) aus Blastozysten erfolgt zu anderen Zwecken als zur Erhaltung des Embryos . Sie i...

[ "Das", "Embryonenschutzgesetz", "verbietet", "jegliche", "fremdnuetzige", "Forschung", "an", "und", "mit", "Embryonen", ".", "Damit", "ist", "in", "Deutschland", "die", "Entnahme", "von", "pluripotenten", "Zellen", "aus", "einem", "Embryo", "verboten", ".", "Die", ...

[ "umlsterm" ]

Embryonenschutzgesetz is an umlsterm, Forschung is an umlsterm, Embryonen is an umlsterm, Deutschland is an umlsterm, Zellen is an umlsterm, Embryo is an umlsterm, Stammzellen is an umlsterm, Embryos is an umlsterm, Embryonenschutzgesetz is an umlsterm, selbst is an umlsterm, Embryo is an umlsterm, Zellen is an umlster...

Reproduktionsmedizin.90150159.ger.abstr_task1

Sentence: Das Embryonenschutzgesetz verbietet jegliche fremdnuetzige Forschung an und mit Embryonen . Damit ist in Deutschland die Entnahme von pluripotenten Zellen aus einem Embryo verboten . Die Gewinnung von embryonalen Stammzellen ( ES-Zellen ) aus Blastozysten erfolgt zu anderen Zwecken als zur Erhaltung des Embry...

[ "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "...

Das Embryonenschutzgesetz verbietet jegliche fremdnuetzige Forschung an und mit Embryonen . Damit ist in Deutschland die Entnahme von pluripotenten Zellen aus einem Embryo verboten . Die Gewinnung von embryonalen Stammzellen ( ES-Zellen ) aus Blastozysten erfolgt zu anderen Zwecken als zur Erhaltung des Embryos . Sie i...

[ "Das", "Embryonenschutzgesetz", "verbietet", "jegliche", "fremdnuetzige", "Forschung", "an", "und", "mit", "Embryonen", ".", "Damit", "ist", "in", "Deutschland", "die", "Entnahme", "von", "pluripotenten", "Zellen", "aus", "einem", "Embryo", "verboten", ".", "Die", ...

[ "umlsterm" ]

Embryonenschutzgesetz, Forschung, Embryonen, Deutschland, Zellen, Embryo, Stammzellen, Embryos, Embryonenschutzgesetz, selbst, Embryo, Zellen, Zellkerntransfer, Eizellen, Stammzellen, Technik, Zellen, Menschen, Deutschland, Stammzellen, Gewebe, Feten, Gewebeentnahme, Verwendung, Zellen, Gewebe, Forschung, Stammzellen, ...

Reproduktionsmedizin.90150159.ger.abstr_task2

Sentence: Das Embryonenschutzgesetz verbietet jegliche fremdnuetzige Forschung an und mit Embryonen . Damit ist in Deutschland die Entnahme von pluripotenten Zellen aus einem Embryo verboten . Die Gewinnung von embryonalen Stammzellen ( ES-Zellen ) aus Blastozysten erfolgt zu anderen Zwecken als zur Erhaltung des Embry...

[ "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "...

Das Embryonenschutzgesetz verbietet jegliche fremdnuetzige Forschung an und mit Embryonen . Damit ist in Deutschland die Entnahme von pluripotenten Zellen aus einem Embryo verboten . Die Gewinnung von embryonalen Stammzellen ( ES-Zellen ) aus Blastozysten erfolgt zu anderen Zwecken als zur Erhaltung des Embryos . Sie i...

[ "Das", "Embryonenschutzgesetz", "verbietet", "jegliche", "fremdnuetzige", "Forschung", "an", "und", "mit", "Embryonen", ".", "Damit", "ist", "in", "Deutschland", "die", "Entnahme", "von", "pluripotenten", "Zellen", "aus", "einem", "Embryo", "verboten", ".", "Die", ...

[ "umlsterm" ]

neurotoxicity is a ADVERSE

example-381_task0

Sentence: Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Environmental and occupational exposure to lead (Pb) remains to be a major public health issue. The purpose of this cross-se...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Environmental and occupational exposure to lead (Pb) remains to be a major public health issue. The purpose of this cross-sectional st...

[ "Evidence", "for", "altered", "hippocampal", "volume", "and", "brain", "metabolites", "in", "workers", "occupationally", "exposed", "to", "lead", ":", "a", "study", "by", "magnetic", "resonance", "imaging", "and", "(", "1)H", "magnetic", "resonance", "spectroscopy...

[ "ADVERSE" ]

neurotoxicity is a ADVERSE

example-381_task1

Sentence: Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Environmental and occupational exposure to lead (Pb) remains to be a major public health issue. The purpose of this cross-se...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Environmental and occupational exposure to lead (Pb) remains to be a major public health issue. The purpose of this cross-sectional st...

[ "Evidence", "for", "altered", "hippocampal", "volume", "and", "brain", "metabolites", "in", "workers", "occupationally", "exposed", "to", "lead", ":", "a", "study", "by", "magnetic", "resonance", "imaging", "and", "(", "1)H", "magnetic", "resonance", "spectroscopy...

[ "ADVERSE" ]

neurotoxicity

example-381_task2

Sentence: Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Environmental and occupational exposure to lead (Pb) remains to be a major public health issue. The purpose of this cross-se...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy. Environmental and occupational exposure to lead (Pb) remains to be a major public health issue. The purpose of this cross-sectional st...

[ "Evidence", "for", "altered", "hippocampal", "volume", "and", "brain", "metabolites", "in", "workers", "occupationally", "exposed", "to", "lead", ":", "a", "study", "by", "magnetic", "resonance", "imaging", "and", "(", "1)H", "magnetic", "resonance", "spectroscopy...

[ "ADVERSE" ]

alpha - UBF antibody is a reagent, UBF is a protein, rDNA is a DNA, FISH is an assay

1.0alpha7.train.1055_task0

Sentence: To demonstrate that the alpha-UBF antibody used here can specifically recognize UBF bound to rDNA, we performed combined immunofluorescence and FISH analysis of metaphase chromosomes isolated from Xenopus cells (Fig. 2). Instructions: please extract entities and their types from the input se...

[ "O", "O", "O", "O", "B-reagent", "I-reagent", "I-reagent", "I-reagent", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "B-DNA", "O", "O", "O", "O", "O", "O", "O", "B-assay", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

To demonstrate that the alpha-UBF antibody used here can specifically recognize UBF bound to rDNA, we performed combined immunofluorescence and FISH analysis of metaphase chromosomes isolated from Xenopus cells (Fig. 2).

[ "To", "demonstrate", "that", "the", "alpha", "-", "UBF", "antibody", "used", "here", "can", "specifically", "recognize", " ", "UBF", "bound", "to", " ", "rDNA", ",", "we", "performed", "combined", "immunofluorescence", "and", " ", "FISH", "analysis", "of", "...

[ "reagent", "DNA", "assay", "protein" ]

alpha - UBF antibody is a reagent, UBF is a protein, rDNA is a DNA, FISH is an assay

1.0alpha7.train.1055_task1

Sentence: To demonstrate that the alpha-UBF antibody used here can specifically recognize UBF bound to rDNA, we performed combined immunofluorescence and FISH analysis of metaphase chromosomes isolated from Xenopus cells (Fig. 2). Instructions: please typing these entity words according to sentence: a...

[ "O", "O", "O", "O", "B-reagent", "I-reagent", "I-reagent", "I-reagent", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "B-DNA", "O", "O", "O", "O", "O", "O", "O", "B-assay", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

To demonstrate that the alpha-UBF antibody used here can specifically recognize UBF bound to rDNA, we performed combined immunofluorescence and FISH analysis of metaphase chromosomes isolated from Xenopus cells (Fig. 2).

[ "To", "demonstrate", "that", "the", "alpha", "-", "UBF", "antibody", "used", "here", "can", "specifically", "recognize", " ", "UBF", "bound", "to", " ", "rDNA", ",", "we", "performed", "combined", "immunofluorescence", "and", " ", "FISH", "analysis", "of", "...

[ "reagent", "DNA", "assay", "protein" ]

alpha - UBF antibody, UBF, rDNA, FISH

1.0alpha7.train.1055_task2

Sentence: To demonstrate that the alpha-UBF antibody used here can specifically recognize UBF bound to rDNA, we performed combined immunofluorescence and FISH analysis of metaphase chromosomes isolated from Xenopus cells (Fig. 2). Instructions: please extract entity words from the input sentence ...

[ "O", "O", "O", "O", "B-reagent", "I-reagent", "I-reagent", "I-reagent", "O", "O", "O", "O", "O", "O", "B-protein", "O", "O", "O", "B-DNA", "O", "O", "O", "O", "O", "O", "O", "B-assay", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", ...

To demonstrate that the alpha-UBF antibody used here can specifically recognize UBF bound to rDNA, we performed combined immunofluorescence and FISH analysis of metaphase chromosomes isolated from Xenopus cells (Fig. 2).

[ "To", "demonstrate", "that", "the", "alpha", "-", "UBF", "antibody", "used", "here", "can", "specifically", "recognize", " ", "UBF", "bound", "to", " ", "rDNA", ",", "we", "performed", "combined", "immunofluorescence", "and", " ", "FISH", "analysis", "of", "...

[ "reagent", "DNA", "assay", "protein" ]

Sp family members is a protein_family_or_group, promoter proximal repeat is a DNA_domain_or_region, HTLV - I enhancer is a DNA_domain_or_region

62654_task0

Sentence: Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: protein_family_or_group, DNA_domain_or_region

[ "B-protein_family_or_group", "I-protein_family_or_group", "I-protein_family_or_group", "O", "O", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain...

Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer.

[ "Sp", "family", "members", "preferentially", "interact", "with", "the", "promoter", "proximal", "repeat", "within", "the", "HTLV", "-", "I", "enhancer", "." ]

[ "cell_type", "other_name", "(AND polynucleotide polynucleotide)", "virus", "DNA_domain_or_region", "", "cell_line", "protein_family_or_group", "protein_complex", "(AND other_name other_name)", "protein_molecule" ]

Sp family members is a protein_family_or_group, promoter proximal repeat is a DNA_domain_or_region, HTLV - I enhancer is a DNA_domain_or_region

62654_task1

Sentence: Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer. Instructions: please typing these entity words according to sentence: Sp family members, promoter proximal repeat, HTLV - I enhancer Options: protein_family_or_group, DNA_domain_or_r...

[ "B-protein_family_or_group", "I-protein_family_or_group", "I-protein_family_or_group", "O", "O", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain...

Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer.

[ "Sp", "family", "members", "preferentially", "interact", "with", "the", "promoter", "proximal", "repeat", "within", "the", "HTLV", "-", "I", "enhancer", "." ]

[ "cell_type", "other_name", "(AND polynucleotide polynucleotide)", "virus", "DNA_domain_or_region", "", "cell_line", "protein_family_or_group", "protein_complex", "(AND other_name other_name)", "protein_molecule" ]

Sp family members, promoter proximal repeat, HTLV - I enhancer

62654_task2

Sentence: Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer. Instructions: please extract entity words from the input sentence

[ "B-protein_family_or_group", "I-protein_family_or_group", "I-protein_family_or_group", "O", "O", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "O", "O", "B-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain_or_region", "I-DNA_domain...

Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer.

[ "Sp", "family", "members", "preferentially", "interact", "with", "the", "promoter", "proximal", "repeat", "within", "the", "HTLV", "-", "I", "enhancer", "." ]

[ "cell_type", "other_name", "(AND polynucleotide polynucleotide)", "virus", "DNA_domain_or_region", "", "cell_line", "protein_family_or_group", "protein_complex", "(AND other_name other_name)", "protein_molecule" ]

Surgery is an umlsterm, therapeutic is an umlsterm, treatment is an umlsterm, tumors is an umlsterm, head is an umlsterm, neck is an umlsterm, dates is an umlsterm, lymph node dissection is an umlsterm, surgery is an umlsterm, plastic is an umlsterm, reconstructive surgery is an umlsterm, surgical is an umlsterm, patie...

MundKieferGesichtschirurgie.0004s142.eng.abstr_task0

Sentence: Surgery is still the primary therapeutic approach in treatment of tumors in the head and neck area , dating back to the early nineteenth century . More than 150 years ago , hemimaxillectomies and mandibular resections as well as hemiglossectomies were already performed by leading surgeons . The block principl...

[ "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...

Surgery is still the primary therapeutic approach in treatment of tumors in the head and neck area , dating back to the early nineteenth century . More than 150 years ago , hemimaxillectomies and mandibular resections as well as hemiglossectomies were already performed by leading surgeons . The block principle we are n...

[ "Surgery", "is", "still", "the", "primary", "therapeutic", "approach", "in", "treatment", "of", "tumors", "in", "the", "head", "and", "neck", "area", ",", "dating", "back", "to", "the", "early", "nineteenth", "century", ".", "More", "than", "150", "years", ...

[ "umlsterm" ]

Surgery is an umlsterm, therapeutic is an umlsterm, treatment is an umlsterm, tumors is an umlsterm, head is an umlsterm, neck is an umlsterm, dates is an umlsterm, lymph node dissection is an umlsterm, surgery is an umlsterm, plastic is an umlsterm, reconstructive surgery is an umlsterm, surgical is an umlsterm, patie...

MundKieferGesichtschirurgie.0004s142.eng.abstr_task1

Sentence: Surgery is still the primary therapeutic approach in treatment of tumors in the head and neck area , dating back to the early nineteenth century . More than 150 years ago , hemimaxillectomies and mandibular resections as well as hemiglossectomies were already performed by leading surgeons . The block principl...

[ "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...

Surgery is still the primary therapeutic approach in treatment of tumors in the head and neck area , dating back to the early nineteenth century . More than 150 years ago , hemimaxillectomies and mandibular resections as well as hemiglossectomies were already performed by leading surgeons . The block principle we are n...

[ "Surgery", "is", "still", "the", "primary", "therapeutic", "approach", "in", "treatment", "of", "tumors", "in", "the", "head", "and", "neck", "area", ",", "dating", "back", "to", "the", "early", "nineteenth", "century", ".", "More", "than", "150", "years", ...

[ "umlsterm" ]

Surgery, therapeutic, treatment, tumors, head, neck, dates, lymph node dissection, surgery, plastic, reconstructive surgery, surgical, patients, development, reconstructive surgery, stages, secondary, flaps, The change, skin, flaps, flaps, tissue, transfer, bone grafting, bone grafting, bone, transfer, donor, five - ye...

MundKieferGesichtschirurgie.0004s142.eng.abstr_task2

Sentence: Surgery is still the primary therapeutic approach in treatment of tumors in the head and neck area , dating back to the early nineteenth century . More than 150 years ago , hemimaxillectomies and mandibular resections as well as hemiglossectomies were already performed by leading surgeons . The block principl...

[ "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"...

Surgery is still the primary therapeutic approach in treatment of tumors in the head and neck area , dating back to the early nineteenth century . More than 150 years ago , hemimaxillectomies and mandibular resections as well as hemiglossectomies were already performed by leading surgeons . The block principle we are n...

[ "Surgery", "is", "still", "the", "primary", "therapeutic", "approach", "in", "treatment", "of", "tumors", "in", "the", "head", "and", "neck", "area", ",", "dating", "back", "to", "the", "early", "nineteenth", "century", ".", "More", "than", "150", "years", ...

[ "umlsterm" ]

CCL3 is a GENE-Y, CCR1 is a GENE-Y

23059626_task0

Sentence: The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: GENE-Y

[ "O", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice.

[ "The", "effect", "of", "CCL3", "and", "CCR1", "in", "bone", "remodeling", "induced", "by", "mechanical", "loading", "during", "orthodontic", "tooth", "movement", "in", "mice", "." ]

[ "GENE-Y", "GENE-N", "CHEMICAL" ]

CCL3 is a GENE-Y, CCR1 is a GENE-Y

23059626_task1

Sentence: The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice. Instructions: please typing these entity words according to sentence: CCL3, CCR1 Options: GENE-Y

[ "O", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice.

[ "The", "effect", "of", "CCL3", "and", "CCR1", "in", "bone", "remodeling", "induced", "by", "mechanical", "loading", "during", "orthodontic", "tooth", "movement", "in", "mice", "." ]

[ "GENE-Y", "GENE-N", "CHEMICAL" ]

CCL3, CCR1

23059626_task2

Sentence: The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice. Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice.

[ "The", "effect", "of", "CCL3", "and", "CCR1", "in", "bone", "remodeling", "induced", "by", "mechanical", "loading", "during", "orthodontic", "tooth", "movement", "in", "mice", "." ]

[ "GENE-Y", "GENE-N", "CHEMICAL" ]

Ramipril is an intervention, progression is an outcome

512_task0

Sentence: Ramipril reduced the risk for any progression ( OR , 0.87 ; 95 % CI , 0.78 to 0.97 ; P = 0.0146 ) . Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: intervention, outcome

[ "B-intervention", "O", "O", "O", "O", "O", "B-outcome", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

Ramipril reduced the risk for any progression ( OR , 0.87 ; 95 % CI , 0.78 to 0.97 ; P = 0.0146 ) .

[ "Ramipril", "reduced", "the", "risk", "for", "any", "progression", "(", "OR", ",", "0.87", ";", "95", "%", "CI", ",", "0.78", "to", "0.97", ";", "P", "=", "0.0146", ")", "." ]

[ "outcome", "intervention" ]

Ramipril is an intervention, progression is an outcome

512_task1

Sentence: Ramipril reduced the risk for any progression ( OR , 0.87 ; 95 % CI , 0.78 to 0.97 ; P = 0.0146 ) . Instructions: please typing these entity words according to sentence: Ramipril, progression Options: intervention, outcome

[ "B-intervention", "O", "O", "O", "O", "O", "B-outcome", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

Ramipril reduced the risk for any progression ( OR , 0.87 ; 95 % CI , 0.78 to 0.97 ; P = 0.0146 ) .

[ "Ramipril", "reduced", "the", "risk", "for", "any", "progression", "(", "OR", ",", "0.87", ";", "95", "%", "CI", ",", "0.78", "to", "0.97", ";", "P", "=", "0.0146", ")", "." ]

[ "outcome", "intervention" ]

Ramipril, progression

512_task2

Sentence: Ramipril reduced the risk for any progression ( OR , 0.87 ; 95 % CI , 0.78 to 0.97 ; P = 0.0146 ) . Instructions: please extract entity words from the input sentence

[ "B-intervention", "O", "O", "O", "O", "O", "B-outcome", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ]

Ramipril reduced the risk for any progression ( OR , 0.87 ; 95 % CI , 0.78 to 0.97 ; P = 0.0146 ) .

[ "Ramipril", "reduced", "the", "risk", "for", "any", "progression", "(", "OR", ",", "0.87", ";", "95", "%", "CI", ",", "0.78", "to", "0.97", ";", "P", "=", "0.0146", ")", "." ]

[ "outcome", "intervention" ]

cisplatin is a CHEMICAL

16876126_task0

Sentence: RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: CHEMICAL

[ "O", "O", "O", "O", "O", "O", "O", "B-CHEMICAL", "O", "O", "O", "O", "O", "O" ]

RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells.

[ "RNA", "interference", "-", "triggered", "reversal", "of", "ABCC2-dependent", "cisplatin", "resistance", "in", "human", "cancer", "cells", "." ]

[ "GENE-N", "CHEMICAL", "GENE-Y" ]

cisplatin is a CHEMICAL

16876126_task1

Sentence: RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells. Instructions: please typing these entity words according to sentence: cisplatin Options: CHEMICAL

[ "O", "O", "O", "O", "O", "O", "O", "B-CHEMICAL", "O", "O", "O", "O", "O", "O" ]

RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells.

[ "RNA", "interference", "-", "triggered", "reversal", "of", "ABCC2-dependent", "cisplatin", "resistance", "in", "human", "cancer", "cells", "." ]

[ "GENE-N", "CHEMICAL", "GENE-Y" ]

cisplatin

16876126_task2

Sentence: RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells. Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "O", "O", "O", "O", "B-CHEMICAL", "O", "O", "O", "O", "O", "O" ]

RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells.

[ "RNA", "interference", "-", "triggered", "reversal", "of", "ABCC2-dependent", "cisplatin", "resistance", "in", "human", "cancer", "cells", "." ]

[ "GENE-N", "CHEMICAL", "GENE-Y" ]

Mn SOD is a Protein, Mn superoxide dismutase is a Protein, Cu , Zn SOD is a Protein, catalase is a Protein, Mn SOD is a Protein, human monocyte nuclear factor - kappaB is a Entity, Mn SOD is a Protein, tumor necrosis factor - alpha is a Protein, macrophage inflammatory protein-1alpha is a Protein, Mn SOD is a Protein, ...

105_task0

Sentence: Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relatio...

[ "O", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", ...

Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relationship and ...

[ "Induction", "of", "Mn", "SOD", "in", "human", "monocytes", "without", "inflammatory", "cytokine", "production", "by", "a", "mutant", "endotoxin", ".", "\n", "Endotoxin", "selectively", "induces", "monocyte", "Mn", "superoxide", "dismutase", "(", "SOD", ")", "wi...

[ "Protein", "Entity" ]

Mn SOD is a Protein, Mn superoxide dismutase is a Protein, Cu , Zn SOD is a Protein, catalase is a Protein, Mn SOD is a Protein, human monocyte nuclear factor - kappaB is a Entity, Mn SOD is a Protein, tumor necrosis factor - alpha is a Protein, macrophage inflammatory protein-1alpha is a Protein, Mn SOD is a Protein, ...

105_task1

Sentence: Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relatio...

[ "O", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", ...

Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relationship and ...

[ "Induction", "of", "Mn", "SOD", "in", "human", "monocytes", "without", "inflammatory", "cytokine", "production", "by", "a", "mutant", "endotoxin", ".", "\n", "Endotoxin", "selectively", "induces", "monocyte", "Mn", "superoxide", "dismutase", "(", "SOD", ")", "wi...

[ "Protein", "Entity" ]

Mn SOD, Mn superoxide dismutase, Cu , Zn SOD, catalase, Mn SOD, human monocyte nuclear factor - kappaB, Mn SOD, tumor necrosis factor - alpha, macrophage inflammatory protein-1alpha, Mn SOD, Mn SOD, tumor necrosis factor - alpha

105_task2

Sentence: Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relatio...

[ "O", "O", "B-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Protein", "I-Protein", "I-Protein", ...

Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Endotoxin selectively induces monocyte Mn superoxide dismutase (SOD) without affecting levels of Cu,Zn SOD, catalase, or glutathione peroxidase. However, little is known about the structure-activity relationship and ...

[ "Induction", "of", "Mn", "SOD", "in", "human", "monocytes", "without", "inflammatory", "cytokine", "production", "by", "a", "mutant", "endotoxin", ".", "\n", "Endotoxin", "selectively", "induces", "monocyte", "Mn", "superoxide", "dismutase", "(", "SOD", ")", "wi...

[ "Protein", "Entity" ]

Surgery is an umlsterm, hyperparathyroidism is an umlsterm, standard is an umlsterm, therapy is an umlsterm, frequency is an umlsterm, testing is an umlsterm, surgery is an umlsterm, evaluation is an umlsterm, surgical is an umlsterm, safety is an umlsterm, retrospective is an umlsterm, analysis is an umlsterm, patient...

DerChirurg.70680141.eng.abstr_task0

Sentence: Surgery for symptomatic hyperparathyroidism remains the standard therapy . Asymptomatic primary hyperparathyroidsm ( pHPT ) is being diagnosed with increasing frequency owing to broad serum testing . Indications for surgery in this setting are controversial . For evaluation of surgical safety we performed a r...

[ "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "...

Surgery for symptomatic hyperparathyroidism remains the standard therapy . Asymptomatic primary hyperparathyroidsm ( pHPT ) is being diagnosed with increasing frequency owing to broad serum testing . Indications for surgery in this setting are controversial . For evaluation of surgical safety we performed a retrospecti...

[ "Surgery", "for", "symptomatic", "hyperparathyroidism", "remains", "the", "standard", "therapy", ".", "Asymptomatic", "primary", "hyperparathyroidsm", "(", "pHPT", ")", "is", "being", "diagnosed", "with", "increasing", "frequency", "owing", "to", "broad", "serum", "...

[ "umlsterm" ]

Surgery is an umlsterm, hyperparathyroidism is an umlsterm, standard is an umlsterm, therapy is an umlsterm, frequency is an umlsterm, testing is an umlsterm, surgery is an umlsterm, evaluation is an umlsterm, surgical is an umlsterm, safety is an umlsterm, retrospective is an umlsterm, analysis is an umlsterm, patient...

DerChirurg.70680141.eng.abstr_task1

Sentence: Surgery for symptomatic hyperparathyroidism remains the standard therapy . Asymptomatic primary hyperparathyroidsm ( pHPT ) is being diagnosed with increasing frequency owing to broad serum testing . Indications for surgery in this setting are controversial . For evaluation of surgical safety we performed a r...

[ "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "...

Surgery for symptomatic hyperparathyroidism remains the standard therapy . Asymptomatic primary hyperparathyroidsm ( pHPT ) is being diagnosed with increasing frequency owing to broad serum testing . Indications for surgery in this setting are controversial . For evaluation of surgical safety we performed a retrospecti...

[ "Surgery", "for", "symptomatic", "hyperparathyroidism", "remains", "the", "standard", "therapy", ".", "Asymptomatic", "primary", "hyperparathyroidsm", "(", "pHPT", ")", "is", "being", "diagnosed", "with", "increasing", "frequency", "owing", "to", "broad", "serum", "...

[ "umlsterm" ]

Surgery, hyperparathyroidism, standard, therapy, frequency, testing, surgery, evaluation, surgical, safety, retrospective, analysis, patients, patients, patients, patients, female, age, patients, sonography, adenoma, catheterization, analysis, patients, patients, procedures, ultrasound, catheterization, Postoperative, ...

DerChirurg.70680141.eng.abstr_task2

Sentence: Surgery for symptomatic hyperparathyroidism remains the standard therapy . Asymptomatic primary hyperparathyroidsm ( pHPT ) is being diagnosed with increasing frequency owing to broad serum testing . Indications for surgery in this setting are controversial . For evaluation of surgical safety we performed a r...

[ "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "...

Surgery for symptomatic hyperparathyroidism remains the standard therapy . Asymptomatic primary hyperparathyroidsm ( pHPT ) is being diagnosed with increasing frequency owing to broad serum testing . Indications for surgery in this setting are controversial . For evaluation of surgical safety we performed a retrospecti...

[ "Surgery", "for", "symptomatic", "hyperparathyroidism", "remains", "the", "standard", "therapy", ".", "Asymptomatic", "primary", "hyperparathyroidsm", "(", "pHPT", ")", "is", "being", "diagnosed", "with", "increasing", "frequency", "owing", "to", "broad", "serum", "...

[ "umlsterm" ]

Wachstum is an umlsterm, Schaedelkorrekturen is an umlsterm, Kraniosynostosen is an umlsterm, Schaedelkonfiguration is an umlsterm, Krankengut is an umlsterm, Kindern is an umlsterm, maennliche is an umlsterm, weibliche is an umlsterm, syndromale is an umlsterm, Kraniosynostosen is an umlsterm, Kraniosynostose is an um...

MundKieferGesichtschirurgie.8002s049.ger.abstr_task0

Sentence: Ziel der prospektiven Studie war es zu untersuchen , ob das postoperative Wachstum nach Schaedelkorrekturen bei Kraniosynostosen perzentilengerecht im Verhaeltnis zu einem Normalkollektiv weiterverlaeuft , da durch die Operation eine normale " Schaedelkonfiguration " erreicht wird . Das Krankengut setzte sich...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", ...

Ziel der prospektiven Studie war es zu untersuchen , ob das postoperative Wachstum nach Schaedelkorrekturen bei Kraniosynostosen perzentilengerecht im Verhaeltnis zu einem Normalkollektiv weiterverlaeuft , da durch die Operation eine normale " Schaedelkonfiguration " erreicht wird . Das Krankengut setzte sich aus 71 Ki...

[ "Ziel", "der", "prospektiven", "Studie", "war", "es", "zu", "untersuchen", ",", "ob", "das", "postoperative", "Wachstum", "nach", "Schaedelkorrekturen", "bei", "Kraniosynostosen", "perzentilengerecht", "im", "Verhaeltnis", "zu", "einem", "Normalkollektiv", "weiterverlae...

[ "umlsterm" ]

Wachstum is an umlsterm, Schaedelkorrekturen is an umlsterm, Kraniosynostosen is an umlsterm, Schaedelkonfiguration is an umlsterm, Krankengut is an umlsterm, Kindern is an umlsterm, maennliche is an umlsterm, weibliche is an umlsterm, syndromale is an umlsterm, Kraniosynostosen is an umlsterm, Kraniosynostose is an um...

MundKieferGesichtschirurgie.8002s049.ger.abstr_task1

Sentence: Ziel der prospektiven Studie war es zu untersuchen , ob das postoperative Wachstum nach Schaedelkorrekturen bei Kraniosynostosen perzentilengerecht im Verhaeltnis zu einem Normalkollektiv weiterverlaeuft , da durch die Operation eine normale " Schaedelkonfiguration " erreicht wird . Das Krankengut setzte sich...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", ...

Ziel der prospektiven Studie war es zu untersuchen , ob das postoperative Wachstum nach Schaedelkorrekturen bei Kraniosynostosen perzentilengerecht im Verhaeltnis zu einem Normalkollektiv weiterverlaeuft , da durch die Operation eine normale " Schaedelkonfiguration " erreicht wird . Das Krankengut setzte sich aus 71 Ki...

[ "Ziel", "der", "prospektiven", "Studie", "war", "es", "zu", "untersuchen", ",", "ob", "das", "postoperative", "Wachstum", "nach", "Schaedelkorrekturen", "bei", "Kraniosynostosen", "perzentilengerecht", "im", "Verhaeltnis", "zu", "einem", "Normalkollektiv", "weiterverlae...

[ "umlsterm" ]

Wachstum, Schaedelkorrekturen, Kraniosynostosen, Schaedelkonfiguration, Krankengut, Kindern, maennliche, weibliche, syndromale, Kraniosynostosen, Kraniosynostose, Kopfumfang, Kraniotomie, Bandes, Kraniosynostosen, Patienten, Patienten, Patient, Kraniosynostosen, Patienten, Patienten, Patient, Kraniosynostosen, Wachstum...

MundKieferGesichtschirurgie.8002s049.ger.abstr_task2

Sentence: Ziel der prospektiven Studie war es zu untersuchen , ob das postoperative Wachstum nach Schaedelkorrekturen bei Kraniosynostosen perzentilengerecht im Verhaeltnis zu einem Normalkollektiv weiterverlaeuft , da durch die Operation eine normale " Schaedelkonfiguration " erreicht wird . Das Krankengut setzte sich...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", ...

Ziel der prospektiven Studie war es zu untersuchen , ob das postoperative Wachstum nach Schaedelkorrekturen bei Kraniosynostosen perzentilengerecht im Verhaeltnis zu einem Normalkollektiv weiterverlaeuft , da durch die Operation eine normale " Schaedelkonfiguration " erreicht wird . Das Krankengut setzte sich aus 71 Ki...

[ "Ziel", "der", "prospektiven", "Studie", "war", "es", "zu", "untersuchen", ",", "ob", "das", "postoperative", "Wachstum", "nach", "Schaedelkorrekturen", "bei", "Kraniosynostosen", "perzentilengerecht", "im", "Verhaeltnis", "zu", "einem", "Normalkollektiv", "weiterverlae...

[ "umlsterm" ]

actin is a protein-family

1.0alpha7.train.98_task0

Sentence: This is contrary to what one would expect if high ionic strength decreases the effect of the mutation on the binding of the regulatory complex to actin. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: protein-famil...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein-family", "O" ]

This is contrary to what one would expect if high ionic strength decreases the effect of the mutation on the binding of the regulatory complex to actin.

[ "This", "is", "contrary", "to", "what", "one", "would", "expect", "if", "high", "ionic", "strength", "decreases", "the", "effect", "of", "the", "mutation", "on", "the", "binding", "of", "the", "regulatory", "complex", "to", "actin", "." ]

[ "protein-family" ]

actin is a protein-family

1.0alpha7.train.98_task1

Sentence: This is contrary to what one would expect if high ionic strength decreases the effect of the mutation on the binding of the regulatory complex to actin. Instructions: please typing these entity words according to sentence: actin Options: protein-family

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein-family", "O" ]

This is contrary to what one would expect if high ionic strength decreases the effect of the mutation on the binding of the regulatory complex to actin.

[ "This", "is", "contrary", "to", "what", "one", "would", "expect", "if", "high", "ionic", "strength", "decreases", "the", "effect", "of", "the", "mutation", "on", "the", "binding", "of", "the", "regulatory", "complex", "to", "actin", "." ]

[ "protein-family" ]

actin

1.0alpha7.train.98_task2

Sentence: This is contrary to what one would expect if high ionic strength decreases the effect of the mutation on the binding of the regulatory complex to actin. Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-protein-family", "O" ]

This is contrary to what one would expect if high ionic strength decreases the effect of the mutation on the binding of the regulatory complex to actin.

[ "This", "is", "contrary", "to", "what", "one", "would", "expect", "if", "high", "ionic", "strength", "decreases", "the", "effect", "of", "the", "mutation", "on", "the", "binding", "of", "the", "regulatory", "complex", "to", "actin", "." ]

[ "protein-family" ]

AT1 receptor is a GENE-Y, BDNF is a GENE-Y

23211364_task0

Sentence: AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: GENE-Y

[ "B-GENE-Y", "I-GENE-Y", "O", "O", "O", "O", "O", "O", "O", "B-GENE-Y", "O", "O", "O", "O" ]

AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.

[ "AT1", "receptor", "antagonism", "is", "proangiogenic", "in", "the", "brain", ":", "BDNF", "a", "novel", "mediator", "." ]

[ "GENE-Y", "GENE-N", "CHEMICAL" ]

AT1 receptor is a GENE-Y, BDNF is a GENE-Y

23211364_task1

Sentence: AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. Instructions: please typing these entity words according to sentence: AT1 receptor, BDNF Options: GENE-Y

[ "B-GENE-Y", "I-GENE-Y", "O", "O", "O", "O", "O", "O", "O", "B-GENE-Y", "O", "O", "O", "O" ]

AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.

[ "AT1", "receptor", "antagonism", "is", "proangiogenic", "in", "the", "brain", ":", "BDNF", "a", "novel", "mediator", "." ]

[ "GENE-Y", "GENE-N", "CHEMICAL" ]

AT1 receptor, BDNF

23211364_task2

Sentence: AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. Instructions: please extract entity words from the input sentence

[ "B-GENE-Y", "I-GENE-Y", "O", "O", "O", "O", "O", "O", "O", "B-GENE-Y", "O", "O", "O", "O" ]

AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.

[ "AT1", "receptor", "antagonism", "is", "proangiogenic", "in", "the", "brain", ":", "BDNF", "a", "novel", "mediator", "." ]

[ "GENE-Y", "GENE-N", "CHEMICAL" ]

Paola is a NOMBRE_SUJETO_ASISTENCIA, Barba Vega is a NOMBRE_SUJETO_ASISTENCIA, 4387459 is a ID_SUJETO_ASISTENCIA, 83 56740786 47 is a ID_ASEGURAMIENTO, Calle Puchaicela , 34 is a CALLE, Madrid is a TERRITORIO, 31250 is a TERRITORIO, 21/07/1981 is a FECHAS, España is a PAIS, 34 años is a EDAD_SUJETO_ASISTENCIA, 10/11/20...

359_task0

Sentence: Datos del paciente. Nombre: Paola. Apellidos: Barba Vega. NHC: 4387459. NASS: 83 56740786 47. Domicilio: Calle Puchaicela, 34 . Localidad/ Provincia: Madrid. CP: 31250. Datos asistenciales. Fecha de nacimiento: 21/07/1981. País de nacimiento: España. Edad: 34 años Sexo: M. Fecha de Ingreso: 10/11/2015. Médico...

[ "O", "O", "O", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "I-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_ASEGURAMIENTO", "I-ID_ASEGURAMIENTO", "I-ID_ASEGU...

Datos del paciente. Nombre: Paola. Apellidos: Barba Vega. NHC: 4387459. NASS: 83 56740786 47. Domicilio: Calle Puchaicela, 34 . Localidad/ Provincia: Madrid. CP: 31250. Datos asistenciales. Fecha de nacimiento: 21/07/1981. País de nacimiento: España. Edad: 34 años Sexo: M. Fecha de Ingreso: 10/11/2015. Médico: Ana M. C...

[ "Datos", "del", "paciente", ".", "\n", "Nombre", ":", "Paola", ".", "\n", "Apellidos", ":", "Barba", "Vega", ".", "\n", "NHC", ":", "4387459", ".", "\n", "NASS", ":", "83", "56740786", "47", ".", "\n", "Domicilio", ":", "Calle", "Puchaicela", ",", "3...

[ "CALLE", "HOSPITAL", "NOMBRE_PERSONAL_SANITARIO", "ID_ASEGURAMIENTO", "ID_TITULACION_PERSONAL_SANITARIO", "NUMERO_TELEFONO", "FECHAS", "NOMBRE_SUJETO_ASISTENCIA", "TERRITORIO", "EDAD_SUJETO_ASISTENCIA", "ID_SUJETO_ASISTENCIA", "PAIS", "SEXO_SUJETO_ASISTENCIA" ]

Paola is a NOMBRE_SUJETO_ASISTENCIA, Barba Vega is a NOMBRE_SUJETO_ASISTENCIA, 4387459 is a ID_SUJETO_ASISTENCIA, 83 56740786 47 is a ID_ASEGURAMIENTO, Calle Puchaicela , 34 is a CALLE, Madrid is a TERRITORIO, 31250 is a TERRITORIO, 21/07/1981 is a FECHAS, España is a PAIS, 34 años is a EDAD_SUJETO_ASISTENCIA, 10/11/20...

359_task1

Sentence: Datos del paciente. Nombre: Paola. Apellidos: Barba Vega. NHC: 4387459. NASS: 83 56740786 47. Domicilio: Calle Puchaicela, 34 . Localidad/ Provincia: Madrid. CP: 31250. Datos asistenciales. Fecha de nacimiento: 21/07/1981. País de nacimiento: España. Edad: 34 años Sexo: M. Fecha de Ingreso: 10/11/2015. Médico...

[ "O", "O", "O", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "I-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_ASEGURAMIENTO", "I-ID_ASEGURAMIENTO", "I-ID_ASEGU...

Datos del paciente. Nombre: Paola. Apellidos: Barba Vega. NHC: 4387459. NASS: 83 56740786 47. Domicilio: Calle Puchaicela, 34 . Localidad/ Provincia: Madrid. CP: 31250. Datos asistenciales. Fecha de nacimiento: 21/07/1981. País de nacimiento: España. Edad: 34 años Sexo: M. Fecha de Ingreso: 10/11/2015. Médico: Ana M. C...

[ "Datos", "del", "paciente", ".", "\n", "Nombre", ":", "Paola", ".", "\n", "Apellidos", ":", "Barba", "Vega", ".", "\n", "NHC", ":", "4387459", ".", "\n", "NASS", ":", "83", "56740786", "47", ".", "\n", "Domicilio", ":", "Calle", "Puchaicela", ",", "3...

[ "CALLE", "HOSPITAL", "NOMBRE_PERSONAL_SANITARIO", "ID_ASEGURAMIENTO", "ID_TITULACION_PERSONAL_SANITARIO", "NUMERO_TELEFONO", "FECHAS", "NOMBRE_SUJETO_ASISTENCIA", "TERRITORIO", "EDAD_SUJETO_ASISTENCIA", "ID_SUJETO_ASISTENCIA", "PAIS", "SEXO_SUJETO_ASISTENCIA" ]

Paola, Barba Vega, 4387459, 83 56740786 47, Calle Puchaicela , 34, Madrid, 31250, 21/07/1981, España, 34 años, 10/11/2015, Ana M. Calvo Benito, 31 31 20250, Mujer, 34 años, Ana M. Calvo Benito, Hospital de Navarra, C/ Irunlarrea , 3, 31008, Pamplona, 848 422179

359_task2

Sentence: Datos del paciente. Nombre: Paola. Apellidos: Barba Vega. NHC: 4387459. NASS: 83 56740786 47. Domicilio: Calle Puchaicela, 34 . Localidad/ Provincia: Madrid. CP: 31250. Datos asistenciales. Fecha de nacimiento: 21/07/1981. País de nacimiento: España. Edad: 34 años Sexo: M. Fecha de Ingreso: 10/11/2015. Médico...

[ "O", "O", "O", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-NOMBRE_SUJETO_ASISTENCIA", "I-NOMBRE_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_SUJETO_ASISTENCIA", "O", "O", "O", "O", "B-ID_ASEGURAMIENTO", "I-ID_ASEGURAMIENTO", "I-ID_ASEGU...

Datos del paciente. Nombre: Paola. Apellidos: Barba Vega. NHC: 4387459. NASS: 83 56740786 47. Domicilio: Calle Puchaicela, 34 . Localidad/ Provincia: Madrid. CP: 31250. Datos asistenciales. Fecha de nacimiento: 21/07/1981. País de nacimiento: España. Edad: 34 años Sexo: M. Fecha de Ingreso: 10/11/2015. Médico: Ana M. C...

[ "Datos", "del", "paciente", ".", "\n", "Nombre", ":", "Paola", ".", "\n", "Apellidos", ":", "Barba", "Vega", ".", "\n", "NHC", ":", "4387459", ".", "\n", "NASS", ":", "83", "56740786", "47", ".", "\n", "Domicilio", ":", "Calle", "Puchaicela", ",", "3...

[ "CALLE", "HOSPITAL", "NOMBRE_PERSONAL_SANITARIO", "ID_ASEGURAMIENTO", "ID_TITULACION_PERSONAL_SANITARIO", "NUMERO_TELEFONO", "FECHAS", "NOMBRE_SUJETO_ASISTENCIA", "TERRITORIO", "EDAD_SUJETO_ASISTENCIA", "ID_SUJETO_ASISTENCIA", "PAIS", "SEXO_SUJETO_ASISTENCIA" ]

Stammzellen is an umlsterm, Wiederherstellung is an umlsterm, Haematopoese is an umlsterm, Therapie is an umlsterm, Behandlung is an umlsterm, Mangelsyndrome is an umlsterm, Stoffwechselkrankheiten is an umlsterm, Transportvehikel is an umlsterm, Gentherapie is an umlsterm, Stammzellen is an umlsterm, Knochenmark is an...

Bundesgesundheitsblatt.90420105.ger.abstr_task0

Sentence: Praeparationen haematopoetischer Stammzellen bieten prinzipiell eine unendliche Vielfalt klinischer Anwendungsmoeglichkeiten und Zukunftsperspektiven . Sie sind die Basis fuer Stammzelltransplantationen , d.h. fuer die Wiederherstellung der Haematopoese nach hochdosierter zytotoxischer Therapie und bilden die...

[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-um...

Praeparationen haematopoetischer Stammzellen bieten prinzipiell eine unendliche Vielfalt klinischer Anwendungsmoeglichkeiten und Zukunftsperspektiven . Sie sind die Basis fuer Stammzelltransplantationen , d.h. fuer die Wiederherstellung der Haematopoese nach hochdosierter zytotoxischer Therapie und bilden die Grundlage...

[ "Praeparationen", "haematopoetischer", "Stammzellen", "bieten", "prinzipiell", "eine", "unendliche", "Vielfalt", "klinischer", "Anwendungsmoeglichkeiten", "und", "Zukunftsperspektiven", ".", "Sie", "sind", "die", "Basis", "fuer", "Stammzelltransplantationen", ",", "d.h", "....

[ "umlsterm" ]

Stammzellen is an umlsterm, Wiederherstellung is an umlsterm, Haematopoese is an umlsterm, Therapie is an umlsterm, Behandlung is an umlsterm, Mangelsyndrome is an umlsterm, Stoffwechselkrankheiten is an umlsterm, Transportvehikel is an umlsterm, Gentherapie is an umlsterm, Stammzellen is an umlsterm, Knochenmark is an...

Bundesgesundheitsblatt.90420105.ger.abstr_task1

Sentence: Praeparationen haematopoetischer Stammzellen bieten prinzipiell eine unendliche Vielfalt klinischer Anwendungsmoeglichkeiten und Zukunftsperspektiven . Sie sind die Basis fuer Stammzelltransplantationen , d.h. fuer die Wiederherstellung der Haematopoese nach hochdosierter zytotoxischer Therapie und bilden die...

[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-um...

Praeparationen haematopoetischer Stammzellen bieten prinzipiell eine unendliche Vielfalt klinischer Anwendungsmoeglichkeiten und Zukunftsperspektiven . Sie sind die Basis fuer Stammzelltransplantationen , d.h. fuer die Wiederherstellung der Haematopoese nach hochdosierter zytotoxischer Therapie und bilden die Grundlage...

[ "Praeparationen", "haematopoetischer", "Stammzellen", "bieten", "prinzipiell", "eine", "unendliche", "Vielfalt", "klinischer", "Anwendungsmoeglichkeiten", "und", "Zukunftsperspektiven", ".", "Sie", "sind", "die", "Basis", "fuer", "Stammzelltransplantationen", ",", "d.h", "....

[ "umlsterm" ]

Stammzellen, Wiederherstellung, Haematopoese, Therapie, Behandlung, Mangelsyndrome, Stoffwechselkrankheiten, Transportvehikel, Gentherapie, Stammzellen, Knochenmark, Blut, Nabelschnurblut, Biologie, Stammzellen, Zulassung, Stammzellen, Arzneimittel, Person, Gebrauch

Bundesgesundheitsblatt.90420105.ger.abstr_task2

Sentence: Praeparationen haematopoetischer Stammzellen bieten prinzipiell eine unendliche Vielfalt klinischer Anwendungsmoeglichkeiten und Zukunftsperspektiven . Sie sind die Basis fuer Stammzelltransplantationen , d.h. fuer die Wiederherstellung der Haematopoese nach hochdosierter zytotoxischer Therapie und bilden die...

[ "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-umlsterm", "O", "O", "O", "B-umlsterm", "O", "O", "O", "O", "O", "B-umlsterm", "O", "B-um...

Praeparationen haematopoetischer Stammzellen bieten prinzipiell eine unendliche Vielfalt klinischer Anwendungsmoeglichkeiten und Zukunftsperspektiven . Sie sind die Basis fuer Stammzelltransplantationen , d.h. fuer die Wiederherstellung der Haematopoese nach hochdosierter zytotoxischer Therapie und bilden die Grundlage...

[ "Praeparationen", "haematopoetischer", "Stammzellen", "bieten", "prinzipiell", "eine", "unendliche", "Vielfalt", "klinischer", "Anwendungsmoeglichkeiten", "und", "Zukunftsperspektiven", ".", "Sie", "sind", "die", "Basis", "fuer", "Stammzelltransplantationen", ",", "d.h", "....

[ "umlsterm" ]

Ifenprodil is a CHEMICAL, Fluorescein is a CHEMICAL, GluN1 is a GENE-Y, GluN2B is a GENE-Y, N - Methyl - D - aspartate Receptor is a GENE-N

23532918_task0

Sentence: Synthesis and in Vitro Characterisation of Ifenprodil-Based Fluorescein Conjugates as GluN1/GluN2B N-Methyl-D-aspartate Receptor Antagonists. Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: GENE-N, GENE-Y, CHEMICAL...

[ "O", "O", "O", "O", "O", "O", "B-CHEMICAL", "O", "O", "B-CHEMICAL", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "B-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "O", "O" ]

Synthesis and in Vitro Characterisation of Ifenprodil-Based Fluorescein Conjugates as GluN1/GluN2B N-Methyl-D-aspartate Receptor Antagonists.

[ "Synthesis", "and", "in", "Vitro", "Characterisation", "of", "Ifenprodil", "-", "Based", "Fluorescein", "Conjugates", "as", "GluN1", "/", "GluN2B", "N", "-", "Methyl", "-", "D", "-", "aspartate", "Receptor", "Antagonists", "." ]

[ "GENE-N", "CHEMICAL", "GENE-Y" ]

Ifenprodil is a CHEMICAL, Fluorescein is a CHEMICAL, GluN1 is a GENE-Y, GluN2B is a GENE-Y, N - Methyl - D - aspartate Receptor is a GENE-N

23532918_task1

Sentence: Synthesis and in Vitro Characterisation of Ifenprodil-Based Fluorescein Conjugates as GluN1/GluN2B N-Methyl-D-aspartate Receptor Antagonists. Instructions: please typing these entity words according to sentence: Ifenprodil, Fluorescein, GluN1, GluN2B, N - Methyl - D - aspartate Receptor ...

[ "O", "O", "O", "O", "O", "O", "B-CHEMICAL", "O", "O", "B-CHEMICAL", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "B-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "O", "O" ]

Synthesis and in Vitro Characterisation of Ifenprodil-Based Fluorescein Conjugates as GluN1/GluN2B N-Methyl-D-aspartate Receptor Antagonists.

[ "Synthesis", "and", "in", "Vitro", "Characterisation", "of", "Ifenprodil", "-", "Based", "Fluorescein", "Conjugates", "as", "GluN1", "/", "GluN2B", "N", "-", "Methyl", "-", "D", "-", "aspartate", "Receptor", "Antagonists", "." ]

[ "GENE-N", "CHEMICAL", "GENE-Y" ]

Ifenprodil, Fluorescein, GluN1, GluN2B, N - Methyl - D - aspartate Receptor

23532918_task2

Sentence: Synthesis and in Vitro Characterisation of Ifenprodil-Based Fluorescein Conjugates as GluN1/GluN2B N-Methyl-D-aspartate Receptor Antagonists. Instructions: please extract entity words from the input sentence

[ "O", "O", "O", "O", "O", "O", "B-CHEMICAL", "O", "O", "B-CHEMICAL", "O", "O", "B-GENE-Y", "O", "B-GENE-Y", "B-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "I-GENE-N", "O", "O" ]

Synthesis and in Vitro Characterisation of Ifenprodil-Based Fluorescein Conjugates as GluN1/GluN2B N-Methyl-D-aspartate Receptor Antagonists.

[ "Synthesis", "and", "in", "Vitro", "Characterisation", "of", "Ifenprodil", "-", "Based", "Fluorescein", "Conjugates", "as", "GluN1", "/", "GluN2B", "N", "-", "Methyl", "-", "D", "-", "aspartate", "Receptor", "Antagonists", "." ]

[ "GENE-N", "CHEMICAL", "GENE-Y" ]

Fluvoxamine is a DRUG, tolbutamide is a DRUG, fluvoxamine is a DRUG, tolbutamide is a DRUG, fluvoxamine is a DRUG, tolbutamide is a DRUG, fluvoxamine is a DRUG, tolbutamide is a DRUG, tolbutamide is a DRUG, tolbutamide is a DRUG, 4-hydroxytolbutamide is a DRUG_N, carboxytolbutamide is a DRUG_N, fluvoxamine is a DRUG, t...

11180037_task0

Sentence: Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy parti...

[ "B-DRUG", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "B-DRUG", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O",...

Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy participants. I...

[ "Fluvoxamine", "inhibits", "the", "CYP2C9", "catalyzed", "biotransformation", "of", "tolbutamide", ".", "OBJECTIVE", ":", "Our", "objective", "was", "to", "examine", "the", "interaction", "between", "fluvoxamine", "and", "tolbutamide", "to", "confirm", "that", "fluv...

[ "DRUG_N", "DRUG" ]

Fluvoxamine is a DRUG, tolbutamide is a DRUG, fluvoxamine is a DRUG, tolbutamide is a DRUG, fluvoxamine is a DRUG, tolbutamide is a DRUG, fluvoxamine is a DRUG, tolbutamide is a DRUG, tolbutamide is a DRUG, tolbutamide is a DRUG, 4-hydroxytolbutamide is a DRUG_N, carboxytolbutamide is a DRUG_N, fluvoxamine is a DRUG, t...

11180037_task1

Sentence: Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy parti...

[ "B-DRUG", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "B-DRUG", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O",...

Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy participants. I...

[ "Fluvoxamine", "inhibits", "the", "CYP2C9", "catalyzed", "biotransformation", "of", "tolbutamide", ".", "OBJECTIVE", ":", "Our", "objective", "was", "to", "examine", "the", "interaction", "between", "fluvoxamine", "and", "tolbutamide", "to", "confirm", "that", "fluv...

[ "DRUG_N", "DRUG" ]

Fluvoxamine, tolbutamide, fluvoxamine, tolbutamide, fluvoxamine, tolbutamide, fluvoxamine, tolbutamide, tolbutamide, tolbutamide, 4-hydroxytolbutamide, carboxytolbutamide, fluvoxamine, tolbutamide, tolbutamide, 4-hydroxytolbutamide, carboxytolbutamide, tolbutamide, tolbutamide, fluvoxamine, Fluvoxamine

11180037_task2

Sentence: Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy parti...

[ "B-DRUG", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-DRUG", "O", "B-DRUG", "O", "O", "O", "B-DRUG", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O",...

Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. METHODS: The study was carried out as an open, randomized, crossover design with 14 healthy participants. I...

[ "Fluvoxamine", "inhibits", "the", "CYP2C9", "catalyzed", "biotransformation", "of", "tolbutamide", ".", "OBJECTIVE", ":", "Our", "objective", "was", "to", "examine", "the", "interaction", "between", "fluvoxamine", "and", "tolbutamide", "to", "confirm", "that", "fluv...

[ "DRUG_N", "DRUG" ]

GrpL is a Protein, SLP-76 is a Protein, SH2 domain - containing protein 76 is a Protein, SLP-76 is a Protein, Vav is a Protein, Grb2-related protein of the lymphoid system is a Protein, GrpL is a Protein, GrpL is a Protein, Grb2 is a Protein, GrpL is a Protein, SLP-76 is a Protein, Sos1 is a Protein, Sos2 is a Protein,...

152_task0

Sentence: GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor molecules. SH2 domain-containing protein 76 (SLP-76) interacts with the guanine nucleotide exchange...

[ "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Pr...

GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor molecules. SH2 domain-containing protein 76 (SLP-76) interacts with the guanine nucleotide exchange factor Va...

[ "GrpL", ",", "a", "Grb2-related", "adaptor", "protein", ",", "interacts", "with", "SLP-76", "to", "regulate", "nuclear", "factor", "of", "activated", "T", "cell", "activation", ".", "\n", "Propagation", "of", "signals", "from", "the", "T", "cell", "antigen", ...

[ "Protein", "Entity" ]

GrpL is a Protein, SLP-76 is a Protein, SH2 domain - containing protein 76 is a Protein, SLP-76 is a Protein, Vav is a Protein, Grb2-related protein of the lymphoid system is a Protein, GrpL is a Protein, GrpL is a Protein, Grb2 is a Protein, GrpL is a Protein, SLP-76 is a Protein, Sos1 is a Protein, Sos2 is a Protein,...

152_task1

Sentence: GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor molecules. SH2 domain-containing protein 76 (SLP-76) interacts with the guanine nucleotide exchange...

[ "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Pr...

GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor molecules. SH2 domain-containing protein 76 (SLP-76) interacts with the guanine nucleotide exchange factor Va...

[ "GrpL", ",", "a", "Grb2-related", "adaptor", "protein", ",", "interacts", "with", "SLP-76", "to", "regulate", "nuclear", "factor", "of", "activated", "T", "cell", "activation", ".", "\n", "Propagation", "of", "signals", "from", "the", "T", "cell", "antigen", ...

[ "Protein", "Entity" ]

GrpL, SLP-76, SH2 domain - containing protein 76, SLP-76, Vav, Grb2-related protein of the lymphoid system, GrpL, GrpL, Grb2, GrpL, SLP-76, Sos1, Sos2, Grb2, Sos1, Sos2, SLP-76, tyrosine, LAT, pp36/38, Grb2, GrpL, Grb2, GrpL, SLP-76, GrpL, SLP-76

152_task2

Sentence: GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor molecules. SH2 domain-containing protein 76 (SLP-76) interacts with the guanine nucleotide exchange...

[ "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Protein", "I-Pr...

GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor molecules. SH2 domain-containing protein 76 (SLP-76) interacts with the guanine nucleotide exchange factor Va...

[ "GrpL", ",", "a", "Grb2-related", "adaptor", "protein", ",", "interacts", "with", "SLP-76", "to", "regulate", "nuclear", "factor", "of", "activated", "T", "cell", "activation", ".", "\n", "Propagation", "of", "signals", "from", "the", "T", "cell", "antigen", ...

[ "Protein", "Entity" ]

células tumorales malignas is a MORFOLOGIA_NEOPLASIA

647_task0

Sentence: Anamnesis Acude a Urgencias al 4º día del 1er ciclo, por cuadro de 24 horas de evolución consistente en palpitaciones y disnea progresiva hasta hacerse de reposo. Afebril en domicilio, sin dolor torácico, ni otra sintomatología acompañante. Ante hipotensión marcada, precisa la instauración de aminas en Urgenc...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

Anamnesis Acude a Urgencias al 4º día del 1er ciclo, por cuadro de 24 horas de evolución consistente en palpitaciones y disnea progresiva hasta hacerse de reposo. Afebril en domicilio, sin dolor torácico, ni otra sintomatología acompañante. Ante hipotensión marcada, precisa la instauración de aminas en Urgencias (norad...

[ "Anamnesis", "\n", "Acude", "a", "Urgencias", "al", "4º", "día", "del", "1er", "ciclo", ",", "por", "cuadro", "de", "24", "horas", "de", "evolución", "consistente", "en", "palpitaciones", "y", "disnea", "progresiva", "hasta", "hacerse", "de", "reposo", ".", ...

[ "MORFOLOGIA_NEOPLASIA" ]

células tumorales malignas is a MORFOLOGIA_NEOPLASIA

647_task1

Sentence: Anamnesis Acude a Urgencias al 4º día del 1er ciclo, por cuadro de 24 horas de evolución consistente en palpitaciones y disnea progresiva hasta hacerse de reposo. Afebril en domicilio, sin dolor torácico, ni otra sintomatología acompañante. Ante hipotensión marcada, precisa la instauración de aminas en Urgenc...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

Anamnesis Acude a Urgencias al 4º día del 1er ciclo, por cuadro de 24 horas de evolución consistente en palpitaciones y disnea progresiva hasta hacerse de reposo. Afebril en domicilio, sin dolor torácico, ni otra sintomatología acompañante. Ante hipotensión marcada, precisa la instauración de aminas en Urgencias (norad...

[ "Anamnesis", "\n", "Acude", "a", "Urgencias", "al", "4º", "día", "del", "1er", "ciclo", ",", "por", "cuadro", "de", "24", "horas", "de", "evolución", "consistente", "en", "palpitaciones", "y", "disnea", "progresiva", "hasta", "hacerse", "de", "reposo", ".", ...

[ "MORFOLOGIA_NEOPLASIA" ]

células tumorales malignas

647_task2

Sentence: Anamnesis Acude a Urgencias al 4º día del 1er ciclo, por cuadro de 24 horas de evolución consistente en palpitaciones y disnea progresiva hasta hacerse de reposo. Afebril en domicilio, sin dolor torácico, ni otra sintomatología acompañante. Ante hipotensión marcada, precisa la instauración de aminas en Urgenc...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "...

Anamnesis Acude a Urgencias al 4º día del 1er ciclo, por cuadro de 24 horas de evolución consistente en palpitaciones y disnea progresiva hasta hacerse de reposo. Afebril en domicilio, sin dolor torácico, ni otra sintomatología acompañante. Ante hipotensión marcada, precisa la instauración de aminas en Urgencias (norad...

[ "Anamnesis", "\n", "Acude", "a", "Urgencias", "al", "4º", "día", "del", "1er", "ciclo", ",", "por", "cuadro", "de", "24", "horas", "de", "evolución", "consistente", "en", "palpitaciones", "y", "disnea", "progresiva", "hasta", "hacerse", "de", "reposo", ".", ...

[ "MORFOLOGIA_NEOPLASIA" ]

F is a Person, age is a Person, 18 to 70 is a Value, American Society of Anesthesiologists ( ASA ) is a Measurement, I e II is a Value, breast cancer is a Condition, DIN 2 e 3 , o LIN 2 e 3 sec . Tavassoli is a Scope, scheduled for is a Mood, nipple - sparing mastectomy is a Condition, simple mastectomy is a Condition,...

NCT02035904_inc_task0

Sentence: F; age 18 to 70 American Society of Anesthesiologists (ASA) I e II; breast cancer ( DIN 2 e 3, o LIN 2 e 3 sec. Tavassoli) scheduled for nipple-sparing mastectomy, simple mastectomy, skin-sparing mastectomy, skin-reducing mastectomy c, lymphnode biopsy and axillary dissection; immediate sub-pectoral prostheti...

[ "B-Person", "O", "B-Person", "B-Value", "I-Value", "I-Value", "O", "B-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "B-Value", "I-Value", "I-Value", "O", "O", "B-Condition", "I-Condition", "O", "B-Scope...

F; age 18 to 70 American Society of Anesthesiologists (ASA) I e II; breast cancer ( DIN 2 e 3, o LIN 2 e 3 sec. Tavassoli) scheduled for nipple-sparing mastectomy, simple mastectomy, skin-sparing mastectomy, skin-reducing mastectomy c, lymphnode biopsy and axillary dissection; immediate sub-pectoral prosthetic reconstr...

[ "F", ";", "age", "18", "to", "70", "\n", "American", "Society", "of", "Anesthesiologists", "(", "ASA", ")", "I", "e", "II", ";", "\n", "breast", "cancer", "(", "DIN", "2", "e", "3", ",", "o", "LIN", "2", "e", "3", "sec", ".", "Tavassoli", ")", ...

[ "Measurement", "Procedure", "Scope", "Condition", "Mood", "Value", "Qualifier", "Person" ]

F is a Person, age is a Person, 18 to 70 is a Value, American Society of Anesthesiologists ( ASA ) is a Measurement, I e II is a Value, breast cancer is a Condition, DIN 2 e 3 , o LIN 2 e 3 sec . Tavassoli is a Scope, scheduled for is a Mood, nipple - sparing mastectomy is a Condition, simple mastectomy is a Condition,...

NCT02035904_inc_task1

Sentence: F; age 18 to 70 American Society of Anesthesiologists (ASA) I e II; breast cancer ( DIN 2 e 3, o LIN 2 e 3 sec. Tavassoli) scheduled for nipple-sparing mastectomy, simple mastectomy, skin-sparing mastectomy, skin-reducing mastectomy c, lymphnode biopsy and axillary dissection; immediate sub-pectoral prostheti...

[ "B-Person", "O", "B-Person", "B-Value", "I-Value", "I-Value", "O", "B-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "B-Value", "I-Value", "I-Value", "O", "O", "B-Condition", "I-Condition", "O", "B-Scope...

F; age 18 to 70 American Society of Anesthesiologists (ASA) I e II; breast cancer ( DIN 2 e 3, o LIN 2 e 3 sec. Tavassoli) scheduled for nipple-sparing mastectomy, simple mastectomy, skin-sparing mastectomy, skin-reducing mastectomy c, lymphnode biopsy and axillary dissection; immediate sub-pectoral prosthetic reconstr...

[ "F", ";", "age", "18", "to", "70", "\n", "American", "Society", "of", "Anesthesiologists", "(", "ASA", ")", "I", "e", "II", ";", "\n", "breast", "cancer", "(", "DIN", "2", "e", "3", ",", "o", "LIN", "2", "e", "3", "sec", ".", "Tavassoli", ")", ...

[ "Measurement", "Procedure", "Scope", "Condition", "Mood", "Value", "Qualifier", "Person" ]

F, age, 18 to 70, American Society of Anesthesiologists ( ASA ), I e II, breast cancer, DIN 2 e 3 , o LIN 2 e 3 sec . Tavassoli, scheduled for, nipple - sparing mastectomy, simple mastectomy, skin - sparing mastectomy, skin - reducing mastectomy, lymphnode biopsy, axillary dissection, immediate, sub - pectoral prosthet...

NCT02035904_inc_task2

Sentence: F; age 18 to 70 American Society of Anesthesiologists (ASA) I e II; breast cancer ( DIN 2 e 3, o LIN 2 e 3 sec. Tavassoli) scheduled for nipple-sparing mastectomy, simple mastectomy, skin-sparing mastectomy, skin-reducing mastectomy c, lymphnode biopsy and axillary dissection; immediate sub-pectoral prostheti...

[ "B-Person", "O", "B-Person", "B-Value", "I-Value", "I-Value", "O", "B-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "I-Measurement", "B-Value", "I-Value", "I-Value", "O", "O", "B-Condition", "I-Condition", "O", "B-Scope...

F; age 18 to 70 American Society of Anesthesiologists (ASA) I e II; breast cancer ( DIN 2 e 3, o LIN 2 e 3 sec. Tavassoli) scheduled for nipple-sparing mastectomy, simple mastectomy, skin-sparing mastectomy, skin-reducing mastectomy c, lymphnode biopsy and axillary dissection; immediate sub-pectoral prosthetic reconstr...

[ "F", ";", "age", "18", "to", "70", "\n", "American", "Society", "of", "Anesthesiologists", "(", "ASA", ")", "I", "e", "II", ";", "\n", "breast", "cancer", "(", "DIN", "2", "e", "3", ",", "o", "LIN", "2", "e", "3", "sec", ".", "Tavassoli", ")", ...

[ "Measurement", "Procedure", "Scope", "Condition", "Mood", "Value", "Qualifier", "Person" ]

YE1998 is a Protein, 2000 is a Protein, Plu0634 is a Protein, Plu0635 is a Protein, P. luminescens is a Organism, plu1330 is a Protein, 1369 is a Protein, plu3217 is a Protein, plu3324 is a Protein, plu4117 is a Protein, plu3668 is a Protein, Y. enterocolitica is a Organism, YE1322 is a Protein, P. luminescens is a Org...

21_task0

Sentence: Repeats-in-toxin (RTX) and other toxins RTX proteins constitute another family of toxins that may contribute to the insecticidal activity of the two pathogens. A putative RTX-family toxin transporter is common to both pathogens (YE1998-2000, Plu0634/Plu0635). The P. luminescens genome comprises a gene cluste...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Prote...

Repeats-in-toxin (RTX) and other toxins RTX proteins constitute another family of toxins that may contribute to the insecticidal activity of the two pathogens. A putative RTX-family toxin transporter is common to both pathogens (YE1998-2000, Plu0634/Plu0635). The P. luminescens genome comprises a gene cluster encoding...

[ "Repeats", "-", "in", "-", "toxin", "(", "RTX", ")", "and", "other", "toxins", "\n", "RTX", "proteins", "constitute", "another", "family", "of", "toxins", "that", "may", "contribute", "to", "the", "insecticidal", "activity", "of", "the", "two", "pathogens", ...

[ "Organism", "Protein", "Chemical" ]

YE1998 is a Protein, 2000 is a Protein, Plu0634 is a Protein, Plu0635 is a Protein, P. luminescens is a Organism, plu1330 is a Protein, 1369 is a Protein, plu3217 is a Protein, plu3324 is a Protein, plu4117 is a Protein, plu3668 is a Protein, Y. enterocolitica is a Organism, YE1322 is a Protein, P. luminescens is a Org...

21_task1

Sentence: Repeats-in-toxin (RTX) and other toxins RTX proteins constitute another family of toxins that may contribute to the insecticidal activity of the two pathogens. A putative RTX-family toxin transporter is common to both pathogens (YE1998-2000, Plu0634/Plu0635). The P. luminescens genome comprises a gene cluste...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Prote...

Repeats-in-toxin (RTX) and other toxins RTX proteins constitute another family of toxins that may contribute to the insecticidal activity of the two pathogens. A putative RTX-family toxin transporter is common to both pathogens (YE1998-2000, Plu0634/Plu0635). The P. luminescens genome comprises a gene cluster encoding...

[ "Repeats", "-", "in", "-", "toxin", "(", "RTX", ")", "and", "other", "toxins", "\n", "RTX", "proteins", "constitute", "another", "family", "of", "toxins", "that", "may", "contribute", "to", "the", "insecticidal", "activity", "of", "the", "two", "pathogens", ...

[ "Organism", "Protein", "Chemical" ]

YE1998, 2000, Plu0634, Plu0635, P. luminescens, plu1330, 1369, plu3217, plu3324, plu4117, plu3668, Y. enterocolitica, YE1322, P. luminescens, Plu3209, X. nematophila, Plu2288, Plu0359, YE2685, Y. enterocolitica, YE2091, P. luminescens ssp . akhurstii strain W14, P. luminescens ssp . laumondii strain TT01, P. luminescen...

21_task2

Sentence: Repeats-in-toxin (RTX) and other toxins RTX proteins constitute another family of toxins that may contribute to the insecticidal activity of the two pathogens. A putative RTX-family toxin transporter is common to both pathogens (YE1998-2000, Plu0634/Plu0635). The P. luminescens genome comprises a gene cluste...

[ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-Prote...

Repeats-in-toxin (RTX) and other toxins RTX proteins constitute another family of toxins that may contribute to the insecticidal activity of the two pathogens. A putative RTX-family toxin transporter is common to both pathogens (YE1998-2000, Plu0634/Plu0635). The P. luminescens genome comprises a gene cluster encoding...

[ "Repeats", "-", "in", "-", "toxin", "(", "RTX", ")", "and", "other", "toxins", "\n", "RTX", "proteins", "constitute", "another", "family", "of", "toxins", "that", "may", "contribute", "to", "the", "insecticidal", "activity", "of", "the", "two", "pathogens", ...

[ "Organism", "Protein", "Chemical" ]

Monitoring is an umlsterm, pressure is an umlsterm

DerRadiologe.80380624.eng.abstr_task0

Sentence: Purpose : Monitoring of intraluminal pressure in standardized enteroclysis . Instructions: please extract entities and their types from the input sentence, all entity types are in options Options: umlsterm

[ "O", "O", "B-umlsterm", "O", "O", "B-umlsterm", "O", "O", "O", "O" ]

Purpose : Monitoring of intraluminal pressure in standardized enteroclysis .

[ "Purpose", ":", "Monitoring", "of", "intraluminal", "pressure", "in", "standardized", "enteroclysis", "." ]

[ "umlsterm" ]